Exhibit 10.1


 





Abtech
Holdings, Inc.


 


CREDIT AGREEMENT


 


This CREDIT AGREEMENT (the
“Agreement”) is dated as of March 23, 2015, (the “Effective Date”) by and between Abtech Holdings,
Inc., a Nevada corporation (together with its subsidiary AbTech Industries, Inc. the “Company”), and Golden
Properties Ltd., (the “Investor”).


 


WHEREAS, the Company
is offering to the Investor the opportunity to purchase a promissory note and warrants from the Company (the “Offering”),
and


 


WHEREAS, the Investor
desires to participate in the Offering and lend to the Company Nine Hundred Fifty Thousand Dollars ($950,000.00) (the “Loan
Amount”); and


 


WHEREAS, the Company
and the Investor desire to define the terms and conditions of such financing;


 


NOW, THEREFORE, in
consideration of the foregoing premises and the covenants contained herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:


 


1.        Loan Facility.


 


a.           The
Investor hereby irrevocably commits to loan to the Company an amount equal to the Loan Amount. The date that the Company receives
certified funds from the Investor for the Loan Amount will be the Funding Date. Within two (2) business days of the Funding Date,
the Company will issue to the Investor a Secured Promissory Note in the form of Exhibit A hereto (the “Secured
Note”) in the principal amount equal to the Loan Amount. The date of the Secured Note will be the Funding Date.


 


b.           The
term of this Agreement will begin on the Effective Date and end on the first to occur of (i) the completion of the financing transaction,
or (ii) 60 days from the Effective Date.


 


c.           Upon
funding of the Loan Amount, the Company agrees to issue to the Investor a warrant in the form of Exhibit B hereto, granting
Investor the right to purchase 475,000 shares of the Company’s common stock (the “Warrant Shares”) (such
warrant, the “Warrant”; together with the Secured Note, the “Securities”). The Warrant will
have an exercise price equal to $0.315 per share (the fair market value of the Company’s common stock on the date of issue
based on the average closing price of the Company’s common stock for the 5 trading days prior to the date of issuance) and
shall be exercisable for a five (5) year period.


 


d.           This
Agreement together with the Exhibits constitutes the “Loan Facility Documents”.


 


e.           Investor’s
commitment in this Agreement is based solely upon the information provided in the Loan Facility Documents and upon the Investor’s
own investigation as to the merits and risks of this transaction.


 


f.            The
Company will deliver originally executed instruments representing the Investor’s Secured Note and Warrant to each Investor
promptly following the Funding Date.


 


g.           The
Investor agrees to remit to the Company the Loan Amount by wire transfer pursuant to the wire instructions set forth on Schedule
1(g).


 


2.          Investor
Representations, Warranties and Agreements. The Investor hereby acknowledges, represents and warrants as follows (with the
understanding that the Company will rely on such representations and warranties in determining, among other matters, the suitability
of this investment for the Investor in order to comply with federal and state securities laws):


 




    	1



    	 



    

 


a.           In
connection with this transaction, the Investor has read this Agreement and the other Loan Facility Documents. The Investor acknowledges
that this Agreement is not intended to set forth all of the information which might be deemed pertinent by an investor who is considering
an investment in the Securities. The Investor further acknowledges that he/she/it is not relying on information other than such
information that has been provided directly by the Company. It being the responsibility of Investor (i) to determine or seek confirmation
of the accuracy of any information supplied by third parties about the Company, (ii) to determine what additional information he/she/it
desires to obtain in evaluating this investment and (iii) to obtain such information directly from the Company.


 


b.           This
offering is limited to persons who are “accredited investors,” as that term is defined in Regulation D under the Securities
Act of 1933, as amended (the “Act”), and who have the financial means and the business, financial and investment
experience and acumen to conduct an investigation as tO the merits and risks of this investment. The Investor hereby represents
that he/SHE/IT has read, is familiar with and understands Rule 501 of Regulation D under the Act. The Investor is an “accredited
investor” as defined in Rule 501(a) of Regulation D, AS AMENDED.


 


c.           The
Investor has had full access to all the information which the Investor (or the Investor’s advisor) considers necessary or
appropriate to make an informed decision with respect to the transaction contemplated by this Agreement. The Investor acknowledges
that the Company has made available to the Investor and the Investor’s advisors the opportunity to examine and copy any contract,
matter or information which the Investor considers relevant or appropriate in connection with this investment and to ask questions
and receive answers relating to any such matters including, without limitation, the financial condition, management, employees,
business, obligation, corporate books and records, budgets, business plans of and other matters relevant to the Company. To the
extent the Investor has not sought information regarding any particular matter, the Investor represents that he or she had and
has no interest in doing so and that such matters are not material to the Investor in connection with the transaction contemplated
by this Agreement. The Investor has accepted the responsibility for conducting the Investor’s own investigation and obtaining
for itself such information as to the foregoing and all other subjects as the Investor deems relevant or appropriate in connection
with the transaction contemplated by this Agreement. The Investor is not relying on any representation, by the Company or otherwise,
other than that contained herein. The Investor acknowledges that no representation regarding projected financial performance or
a projected rate of return has been made to it by any party.


 


d.           The
Investor understands that the offering of the Securities has not been registered under the Act, in reliance on an exemption for
private offerings provided pursuant to Section 4(2) of the Act and that, as a result, the Securities and the Warrant Shares will
be “restricted securities” as that term is defined in Rule 144 under the Act and, accordingly, under Rule 144, that
the Securities and the Warrant Shares are all subject to a holding period unless such Securities and the Warrant Shares are subsequently
registered under the Act and qualified under any other applicable securities law or exemptions from such registration and qualification
are available. The Investor understands that the Company is under no obligation to register Securities and the Warrant Shares under
the Act or to register or qualify the Securities or the Warrant Shares under any other applicable securities law, or to comply
with any other exemption under the Act or any other securities law, and that the Investor has no right to require such registration.
The Investor further understands that the Offering of the Securities has not been qualified or registered under any foreign or
state securities laws in reliance upon the representations made and information furnished by the Investor herein and any other
documents delivered by the Investor in connection with this subscription; that the Offering has not been reviewed by the SEC or
by any foreign or state securities authorities; that the Investor’s rights to transfer the Securities will be restricted,
which includes restrictions against transfers unless the transfer is not in violation of the Act and applicable state securities
laws (including investor suitability standards); and that the Company may in its sole discretion require the Investor to provide
at Investor’s own expense an opinion of its counsel to the effect that any proposed transfer is not in violation of the Act
or any state securities laws.


 


e.           The
Investor is empowered and duly authorized to enter into this Credit Agreement which constitutes a valid and binding agreement of
the Investor enforceable against the Investor in accordance with its terms; and the person signing this Credit Agreement on behalf
of the Investor is empowered and duly authorized to do so.


 


f.            The
Investor acknowledges that there will be no public market for the Securities and that the Investor may not be able to sell or dispose
of them; the Investor has liquid assets sufficient to assure that the Purchase Price of the Securities will cause no undue financial
difficulties and that, after purchasing the Securities the Investor will be able to provide for any foreseeable current needs and
possible personal contingencies; the Investor is able to bear the risk of illiquidity and the risk of a complete loss of this investment.


 




    	2



    	 



    

 


g.           The
information in any documents delivered by the Investor in connection with this Agreement, including, but not limited to the Investor
Questionnaire attached as Exhibit C, is true, correct and complete in all respects as of the date hereof. The Investor agrees
promptly to notify the Company in writing of any change in such information after the date hereof.


 


h.           The
offering and sale of the Securities to the Investor were not made through any advertisement in printed media of general and regular
paid circulation, radio or television or any other form of advertisement, or as part of a general solicitation.


 


i.            The
Investor recognizes that an investment in the Securities involves significant risks, including the Risk Factors annexed hereto
as Exhibit D. Investor has read and understands such risks and that such risks, and others, can result in the loss of the
Investor’s entire investment in the Securities.


 


j.            The
Investor is acquiring the Securities, as principal, for the Investor’s own account for investment purposes only, and not
with a present intention toward or for the resale, distribution or fractionalization thereof, and no other person has a beneficial
interest in the Securities. The Investor has no present intention of selling or otherwise distributing or disposing of the Securities,
and understands that an investment in the Securities must be considered a long-term illiquid investment.


 


3.          Representations,
Warranties and Covenants of the Company. Unless otherwise noted below each representation, warranty and covenant is hereby
being made the Company. As a material inducement of the Investors to enter into this Credit Agreement, the Company represents and
warrants to the Investor, as of the date hereof, as follows:


 


a.           Organization
and Standing. The Company is a duly organized corporation, validly existing and in good standing under the laws of the State
of Nevada, has full power to carry on its business as and where such business is now being conducted and to own, lease and operate
the properties and assets now owned or operated by it and is duly qualified to do business and is in good standing in each jurisdiction
where the conduct of its business or the ownership of its properties requires such qualification except where the failure to be
so qualified would not have a Material Adverse Effect on the Company. “Material Adverse Effect” means any circumstance,
change in, or effect on the Company that, individually or in the aggregate with any other similar circumstances, changes in, or
effects on, the Company taken as a whole: (i) is, or is reasonably expected to be, materially adverse to the business, operations,
assets, liabilities, employee relationships, customer or supplier relationships, prospects, results of operations or the condition
(financial or otherwise) of the Company taken as a whole, or (ii) is reasonably expected to adversely affect the ability of the
Company to operate or conduct the Company’s business in the manner in which it is currently operated or conducted or proposed
to be operated or conducted by the Company; provided, however, that none of the following shall be deemed in and
of themselves, either alone or in combination, to constitute, and none of the following shall be taken into account in determining
whether there has been or will be, a Material Adverse Effect: (i) any change, event, state of facts or development generally affecting
the general political, economic or business conditions of the United States; (ii) any change, event, state of facts or development
generally affecting our industry; (iii) any change, event, state of facts or development arising from or relating to compliance
with the terms of this Credit Agreement; (iv) acts of war (whether or not declared), the commencement, continuation or escalation
of a war, acts of armed hostility, sabotage or terrorism or other international or national calamity or any material worsening
of such conditions; (v) changes in laws or generally accepted accounting principles (“GAAP”) after date hereof
or interpretation thereof; or (vi) any matter set forth in the Loan Facility Documents or the Schedules or Exhibits thereto.


 


b.           Authority.
The execution, delivery and performance of this Agreement and the Loan Facility Documents by the Company and its affiliates and
the consummation of the transactions contemplated hereby have been duly authorized by the Board of Directors of the Company. Each
of the documents contained in the Loan Facility Documents has been (or upon delivery will be) duly executed by the Company is or,
when delivered in accordance with the terms hereof, will constitute, assuming due authorization, execution and delivery by each
of the parties thereto, the valid and binding obligation of the Company enforceable against the Company in accordance with its
terms.


 


c.           No
Conflict. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby
do not (i) violate or conflict with the Company’s Certificate of Incorporation, By-laws or other organizational documents,
(ii) conflict with or result (with the lapse of time or giving of notice or both) in a material breach or default under any material
agreement or instrument to which the Company is a party or by which the Company is otherwise bound, or (iii) violate any order,
judgment, law, statute, rule or regulation applicable to the Company, except where such violation, conflict or breach would not
have a Material Adverse Effect on the Company. This Credit Agreement when executed by the Company will be a legal, valid and binding
obligation of the Company enforceable in accordance with its terms (except as may be limited by bankruptcy, insolvency, reorganization,
moratorium and similar laws and equitable principles relating to or limiting creditors’ rights generally).


 




    	3



    	 



    

 


d.           Litigation
and Other Proceedings. There are no actions, suits, proceedings or investigations pending or, to the knowledge of the Company,
threatened against the Company at law or in equity before or by any court or Federal, state, municipal or their governmental department,
commission, board, bureau, agency or instrumentality, domestic or foreign which could materially adversely affect the Company.
The Company is not subject to any continuing order, writ, injunction or decree of any court or agency against it which would have
a material adverse effect on the Company.


 


e.           Consents/Approvals.
No consents, filings (other than Federal and state securities filings relating to the issuance of the Securities pursuant to applicable
exemptions from registration, which the Company hereby undertakes to make in a timely fashion), authorizations or other actions
of any governmental authority are required to be obtained or made by the Company for the Company’s execution, delivery and
performance of this Agreement which have not already been obtained or made or will be made in a timely manner following the Closing.


 


f.            No
Commissions. The Company has not incurred any obligation for any finder’s, broker’s or agent’s fees or commissions
in connection with the transaction contemplated hereby other than as disclosed to the Investor.


 


4.          Legends.
The Investor understands and agrees that the Company will cause any necessary legends to be placed upon any instruments(s) evidencing
ownership of the Securities or the Warrant Shares, together with any other legend that may be required by federal or state securities
laws or deemed necessary or desirable by the Company.


 


5.          General
Provisions.


 


a.           Confidentiality.
The Investor covenants and agrees that it will keep confidential and will not disclose or divulge any confidential or proprietary
information that such Investor may obtain from the Company pursuant to financial statements, reports, and other materials submitted
by the Company to such Investor in connection with this offering or as a result of discussions with or inquiry made to the Company,
unless such information is known, or until such information becomes known, to the public through no action by the Investor; provided,
however, that a Investor may disclose such information to its attorneys, accountants, consultants, assignees or transferees
and other professionals to the extent necessary in connection with his or her investment in the Company so long as any such professional
to whom such information is disclosed is made aware of the Investor’s obligations hereunder and such professional agrees
to be likewise bound as though such professional were a party hereto.


 


b.           Successors.
The covenants, representations and warranties contained in this Credit Agreement shall be binding on the Investor’s and the
Company’s heirs and legal representatives and shall inure to the benefit of the respective successors and assigns of the
Company. The rights and obligations of this Credit Agreement may not be assigned by any party without the prior written consent
of the other party.


 


c.           Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed an original agreement, but all of which together
shall constitute one and the same instrument. 


 


d.           Execution
by Facsimile. Execution and delivery of this Agreement by facsimile transmission (including the delivery of documents in Adobe
PDF format) shall constitute execution and delivery of this Agreement for all purposes, with the same force and effect as execution
and delivery of an original manually signed copy hereof.


 


e.           Governing
Law and Jurisdiction. This Credit Agreement shall be governed by and construed in accordance with the laws of the State of
New York applicable to contracts to be wholly performed within such state and without regard to conflicts of laws provisions. THE
PARTIES HERETO EACH HEREBY IRREVOCABLY AND UNCONDITIONALLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS
SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN. THE PARTIES HERETO EACH AGREE THAT ALL ACTIONS OR PROCEEDINGS ARISING OUT
OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT AND/OR THE OFFERING DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY MUST BE LITIGATED
EXCLUSIVELY IN ANY SUCH STATE OR FEDERAL COURT THAT SITS IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, AND ACCORDINGLY, THE PARTIES
EACH IRREVOCABLY WAIVE ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF ANY SUCH LITIGATION IN ANY
SUCH COURT. Each of the Investor and Company hereby irrevocably waive and agree not to assert, by way of motion, as a defense,
or otherwise, in every suit, action or other proceeding arising out of or based on this Credit Agreement and/or the Loan Facility
Documents and brought in any such court, any claim that Investor or the Company is not subject personally to the jurisdiction of
the above named courts, that Investor’s or the Company’s property, as applicable, is exempt or immune from attachment
or execution, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or
proceeding is improper.


 




    	4



    	 



    

 


f.            (i)          Indemnification
Generally. The Company, on the one hand, and the Investor, on the other hand (each an “Indemnifying Party”),
shall indemnify the other from and against any and all losses, damages, liabilities, claims, charges, actions, proceedings, demands,
judgments, settlement costs and expenses of any nature whatsoever (including, without limitation, reasonable attorneys’ fees
and expenses) resulting from any breach of a representation and warranty, covenant or agreement by the Indemnifying Party and all
claims, charges, actions or proceedings incident to or arising out of the foregoing. Notwithstanding any provision herein to the
contrary, the indemnification obligation of any Investor shall be limited to the principal amount of the Secured Notes issued to
such Investor.


 


(ii)         Indemnification
Procedures. Each person entitled to indemnification under this Section 6 (an “Indemnified Party”) shall
give notice as promptly as reasonably practicable to each party required to provide indemnification under this Section 6 of any
action commenced against or by it in respect of which indemnity may be sought hereunder, but failure to so notify an Indemnifying
Party shall not release such Indemnifying Party from any liability that it may have, otherwise than on account of this indemnity
agreement so long as such failure shall not have materially prejudiced the position of the Indemnifying Party. Upon such notification,
the Indemnifying Party shall assume the defense of such action if it is a claim brought by a third party, and, if and after such
assumption, the Indemnifying Party shall not be entitled to reimbursement of any expenses incurred by it in connection with such
action except as described below. In any such action, any Indemnified Party shall have the right to retain its own counsel, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Party unless (i) the Indemnifying Party and the
Indemnified Party shall have mutually agreed to the contrary or (ii) the named parties in any such action (including any impleaded
parties) include both the Indemnifying Party and the Indemnified Party and representation of both parties by the same counsel would
be inappropriate due to actual or potential differing or conflicting interests between them. The Indemnifying Party shall not be
liable for any settlement of any proceeding effected without its written consent (which shall not be unreasonably withheld or delayed
by such Indemnifying Party), but if settled with such consent or if there be final judgment for the plaintiff, the Indemnifying
Party shall indemnify the Indemnified Party from and against any loss, damage or liability by reason of such settlement or judgment.


 


g.           Notices.
All notices, requests, demands, claims and other communications hereunder shall be in writing and shall be delivered by certified
or registered mail (first class postage pre-paid), guaranteed overnight delivery, or facsimile transmission if such transmission
is confirmed by delivery by certified or registered mail (first class postage pre-paid) or guaranteed overnight delivery, to the
following addresses and facsimile numbers (or to such other addresses or facsimile numbers which such party shall subsequently
designate in writing to the other party):


 


(i)          if
to the Issuer:


 


Glenn R. Rink, President and C.E.O.


AbTech Holdings, Inc.


4110 N. Scottsdale Rd., Suite 235


Scottsdale, AZ 85251


 


with a copy to:


 


Ballard Spahr LLP


1 East Washington Street


Suite 2300


Phoenix, AZ 85004-2555


Attn: Travis Leach


 


(ii)         if
to the Investor to the address set forth next to its name on the signature page hereto.


 




    	5



    	 



    

 


h.           Entire
Agreement. This Credit Agreement (including the Exhibits attached hereto) and other Loan Facility Documents delivered at the
Closing pursuant hereto, contain the entire understanding of the parties in respect of its subject matter and supersedes all prior
agreements and understandings between or among the parties with respect to such subject matter. The Exhibits constitute a part
hereof as though set forth in full above.


 


i.            Amendment;
Waiver. This Credit Agreement may not be modified, amended, supplemented, canceled or discharged, except by written instrument
executed by the Company and the holders of not less than a majority of the principal amount of the Secured Notes. No failure to
exercise, and no delay in exercising, any right, power or privilege under this Credit Agreement shall operate as a waiver, nor
shall any single or partial exercise of any right, power or privilege hereunder preclude the exercise of any other right, power
or privilege. No waiver of any breach of any provision shall be deemed to be a waiver of any proceeding or succeeding breach of
the same or any other provision, nor shall any waiver be implied from any course of dealing between the parties. No extension of
time for performance of any obligations or other acts hereunder or under any other agreement shall be deemed to be an extension
of the time for performance of any other obligations or any other acts. The rights and remedies of the parties under this Credit
Agreement are in addition to all other rights and remedies, at law or equity, that they may have against each other.


 


j.            Payments
on the Secured Notes. Each of the Investors hereto agrees that all payments on the Secured Notes (including any accrued interest
thereon) by the Company will be paid pro rata to the holders thereof based upon the principal amount then outstanding to each of
such holders.


 


k.          No
Impairment. At all times after the date hereof, the Company will not take or permit any action, or cause or permit any subsidiary
to take or permit any action that materially impairs or adversely affects the rights of the Investors under the this Agreement,
the Secured Note or any of the other Loan Facility Documents.


 


l.            Review
by Counsel. The Investor acknowledges and agrees that he/she/it has had the opportunity to review this Agreement with legal
counsel and other advisors of their choosing.


 


IN WITNESS WHEREOF, the
Company has executed this Agreement as of the date first written above.


 


	 	AbTech Holdings, Inc.
	 	 	 
	 	By:	/s/Glenn R. Rink
	 	Name:	Glenn R. Rink
	 	Title:	President and CEO
	 	 
	 	AbTech INDUSTRIES, Inc.
	 	 	 
	 	By:	/s/ Glenn R. Rink
	 	Name:	Glenn R. Rink
	 	Title:	President and CEO
	 	 
	 	INVESTOR
	 	 
	 	Name in which Note and Warrant should be issued:
	 	 
	 	/s/ Golden Properties Ltd


 




    	6



    	 



    

 


EXHIBIT A


 


THE SECURITIES REPRESENTED BY THIS SECURED
NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE OFFERED FOR SALE OR
SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAW OR UPON ISSUANCE
OF AN OPINION OF COUNSEL (SATISFACTORY TO THE COMPANY) THAT SUCH SALES ARE PERMISSIBLE UNDER RULE 144 OR PURSUANT TO AN EXEMPTION
FROM SUCH REGISTRATION REQUIREMENTS.


 





ABTECH HOLDINGS, INC.


 


SECURED PROMISSORY NOTE


 


	$950,000	Dated: March 23, 2015
	(Original Principal Amount)	(“Issuance Date”)


 


FOR VALUE RECEIVED ABTECH
HOLDINGS, INC., a company organized under the laws of Nevada (the “Company”), hereby promises to pay to Golden
Properties Ltd. (the “Payee”), or its registered assigns, the principal amount of Nine Hundred Fifty Thousand
Dollars ($950,000.00 USD) together with interest thereon calculated from the Issuance Date (“Interest Commencement Date”)
in accordance with the provisions of this Secured Promissory Note (as amended, modified and supplemented from time to time, this
“Secured Note”).


 


Certain capitalized terms are defined in Section
9 hereof.


 


1.          Payment
of Interest. Interest shall accrue on the unpaid principal amount of this Secured Note at a rate equal to seven and one-half
percent (7.50%) per annum (the “Interest Rate”) beginning on the Interest Commencement Date.  The Company
shall pay Payee all accrued interest on this Secured Note at maturity. Following any Event of Default (as defined below), interest
on this Secured Note shall accrue, to the extent permitted by law, at a rate equal to the lesser of fifteen percent (15%) per annum
or the maximum rate permitted by applicable law, through the date on which such Event of Default ceases to exist. Interest shall
be computed on the basis of the actual number of days elapsed and a 365-day year. In the event that the Company exercises its first
extension option to extend the Maturity Date (as defined below) by an additional ninety (90) day period (the “First Extension
Option”; and the expiration of such ninety (90) day period the “First Extension Maturity Date”), the
interest rate shall increase to nine and one-half percent (9.5%) per annum on the unpaid principal on this Secured Note beginning
on the Maturity Date (as defined in Section 2).  In the event that the Company exercises its second extension option to extend
the First Extension Maturity Date by an additional ninety (90) day period (the “Second Extension Option”), the
interest rate shall increase to eleven and one-half percent (11.5%) per annum on the unpaid principal on this Secured Note beginning
on the First Extension Maturity Date.  Each of the First Extension Option and Second Extension Option may be referred to individually
as an “Extension Option” or collectively as the “Extension Options”. The Company may exercise
the First Extension Option by providing the Payee with written notice of such exercise fifteen (15) days prior to the Maturity
Date. The Company may exercise the Second Extension Option by providing the Payee with written notice of such exercise fifteen
(15) days prior to the First Extension Maturity Date. NOTWITHSTANDING THE FOREGOING, IN NO EVENT WILL THE APPLICABLE INTEREST RATE
ON THIS SECURED NOTE EVER EXCEED THE MAXIMUM RATE PERMITTED UNDER APPLICABLE LAW.  IF, BUT FOR THE PRECEDING SENTENCE, THE
INTEREST RATE ON THIS SECURED NOTE FOR ANY PERIOD WOULD EXCEED THE MAXIMUM RATE PERMITTED UNDER APPLICABLE LAW, THE INTEREST RATE
FOR SUCH PERIOD SHALL BE REDUCED TO THE MAXIMUM RATE PERMITTED UNDER APPLICABLE LAW. The number of Warrant Shares (as defined in
the Common Stock Purchase Warrant (the “Warrant”)) that Payee shall be entitled to under the terms of the Warrant
issued by the Company to Payee in connection with the Offering shall be increased by ten percent (10%) for each Extension Option
exercised by the Company.


 


2.          Maturity
Date. The entire principal amount of this Secured Note and all accrued but unpaid interest thereon shall be due and payable
in full in cash in immediately available funds on March 23, 2016 (such date, the “Maturity Date”).


 




    	A-1



    	 



    

 


3.          Prepayment.
The Company may prepay all or any portion of the outstanding principal and accrued interest of this Secured Note at any time and
from time to time without penalty or charge upon fifteen (15) days prior written notice to Lender provided that any accrued but
unpaid interest up to the date of prepayment must be paid in full at the time of prepayment.


 


4.          Seniority;
Additional Issuances of Debt and Equity. This Secured Note shall have a security interest in the Collateral (as defined in
Section 10), that is prior to any other security interest in the Collateral except that such security interest shall be
junior to the senior security interest of the secured notes issued by the Company in a $2,000,000 private offering in March –
May of 2014 (the “Senior Notes”) and furthermore, the security interest of this Secured Note shall be pari passu to
the security interest of the secured notes issued by the Company in a $3,000,000 private offering in August – November of
2014 (the “Other Secured Notes”). The Company shall use the proceeds of this Secured Note to repay $875,000 of the
Senior Notes that mature in March, 2015, including any accrued interest due thereon. So long as this Secured Note is outstanding,
the Company shall not incur any additional indebtedness that is senior to this Secured Note, whether with respect to interest,
damages or upon liquidation or dissolution or otherwise, and the Company will not, and will not permit any subsidiary to, directly
or indirectly, incur any Lien on or with respect to any of its property or assets now owned or hereafter acquired or any interest
therein or any income or profits therefrom.


 


(b)          So
long as this Secured Note is outstanding, neither the Company nor any Subsidiary shall, directly or indirectly, (i) redeem, purchase
or otherwise acquire any capital stock or set aside any monies for such a redemption, purchase or other acquisition or (ii) issue
any common stock or common stock equivalents with an effective price or a number of underlying shares that floats or resets or
otherwise varies or is subject to adjustment based (directly or indirectly) on market prices of the common stock.


 


(c)          Notwithstanding
anything to the contrary herein, the Company shall be permitted to, without the consent of the Payees: (i) incur additional unsecured
indebtedness provided, that such additional indebtedness is subordinate to this Secured Note, and (ii) issue additional shares
of its common stock.


 


5.          Method
of Payments.


 


(i)          Payment.
So long as a Payee or any of its nominees shall be the holder of this Secured Note, and notwithstanding anything contained elsewhere
in this Secured Note to the contrary, the Company will pay all sums for principal, interest, or otherwise becoming due on this
Secured Note held by the Payee or such nominee not later than 3:00 p.m. New York time, on the date such payment is due, in immediately
available funds, in accordance with the payment instructions that the Payee may designate in writing, without the presentation
or surrender of such Secured Note or the making of any notation thereon. Any payment made after 3:00 p.m. New York time, on a Business
Day will be deemed made on the next following Business Day. If the due date of any payment in respect of this Secured Note would
otherwise fall on a day that is not a Business Day, such due date shall be extended to the next succeeding Business Day, and interest
shall be payable on any principal so extended for the period of such extension. All amounts payable under this Secured Note shall
be paid free and clear of, and without reduction by reason of, any deduction, set-off or counterclaim. The Company will afford
the benefits of this Section to the Payee and to each other Person holding this Secured Note.


 


(ii)         Transfer
and Exchange. Upon surrender of any Secured Note for registration of transfer or for exchange to the Company at its principal
office, the Company at its sole expense will execute and deliver in exchange therefor a new Secured Note or Secured Notes, as the
case may be, as requested by the holder or transferee, which aggregate principal amount is equal to the unpaid principal amount
of such Secured Note, registered as such holder or transferee may request, dated so that there will be no loss of interest on the
Secured Note and otherwise of like tenor; provided that this Secured Note may not be transferred by Payee to any Person other than
Payee’s affiliates without the prior written consent of the Company (which consent shall not be unreasonably withheld or
delayed). The issuance of new Secured Notes shall be made without charge to the holder(s) of the surrendered Secured Note for any
issuance tax in respect thereof or other cost incurred by the Company in connection with such issuance, provided that each Secured
Noteholder shall pay any transfer taxes associated therewith. The Company shall be entitled to regard the registered holder of
this Secured Note as the holder of the Secured Note so registered for all purposes until the Company or its agent, as applicable,
is required to record a transfer of this Secured Note on its register.


 


(iii)        Replacement.
Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of any Secured Note
and, in the case of any such loss, theft or destruction of any Secured Note, upon receipt of an indemnity reasonably satisfactory
to the Company or, in the case of any such mutilation, upon the surrender and cancellation of such Secured Note, the Company, at
its expense, will execute and deliver, in lieu thereof, a new Secured Note of like tenor and dated the date of such lost, stolen,
destroyed or mutilated Secured Note.


 




    	A-2



    	 



    

 


6.          Covenants
of the Company. The Company covenants and agrees as follows:


 


(i)          Consolidation,
Merger and Sale. The Company will not (a) consolidate or merge with or into (or permit any subsidiary to consolidate or merge
with or into) any other person other than a subsidiary (where the pre-existing stockholders of the Company will own a majority
of the voting stock of the surviving entity), or (b) sell or otherwise dispose of (or permit any subsidiary to sell or otherwise
dispose of) a material portion of its property or assets in one or more transactions to, any other person or entity or enter into
(or permit any subsidiary to enter into) an agreement with respect to any of the foregoing without the prior consent of the Payee.


 


(ii)         Restricted
Payments. The Company will not declare or pay any dividends on, or make any other distribution or payment on account of, or
redeem, retire, purchase or otherwise acquire, directly or indirectly, any equity interests of any class of the Company or any
subsidiary, whether now or hereafter outstanding, or make any other distribution in respect thereof, either directly or indirectly,
whether in cash, property or in obligations of the Company or any of its subsidiaries.


 


(iii)        Reporting
Requirements. For as long as the Company is subject to the periodic reporting requirements of the Securities Exchange Act of
1934 as amended (the “Exchange Act”) the Company shall file all documents and reports with the Securities and
Exchange Commission that it is required to file under the Exchange Act and each such document or report will, at the time of such
filing, (i) comply as to form with the requirements of the Exchange Act and (ii) not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements contained therein not misleading.


 


7.          Events
of Default. If any of the following events takes place before the Maturity Date (each, an “Event of Default”),
Payee, after providing the Company with written notice and a reasonable opportunity to cure, may declare all principal and accrued
and unpaid interest thereon and all other amounts payable under this Secured Note immediately due and payable; provided,
however, that this Secured Note shall automatically become due and payable without any declaration in the case of an Event
of Default specified in clause (iii) or (v), below:


 


		(i)	Company fails to make payment of any amount when due
under this Secured Note; or



 


		(ii)	A receiver, liquidator or trustee of Company or any substantial
part of Company’s assets or properties is appointed by a court order; or



 


		(iii)	Company is adjudicated bankrupt or insolvent; or



 


		(iv)	Any of Company’s property is sequestered by or
in consequence of a court order and such order remains in effect for more than 30 days; or



 


		(v)	Company files a petition in voluntary bankruptcy or requests
reorganization under any provision of any bankruptcy, reorganization or insolvency law or consents to the filing of any petition
against it under such law, or



 


		(vi)	Any petition against Company is filed under bankruptcy,
receivership or insolvency law; or



 


		(vii)	Company makes a formal or informal general assignment
for the benefit of its creditors, or admits in writing its inability to pay debts generally when they become due, or consents
to the appointment of a receiver or liquidator of Company or of all or any part of its property; or



 


		(viii)	An attachment or execution is levied against any substantial
part of Company’s assets that is not released within 30 days; or



 


		(ix)	Company dissolves, liquidates or ceases business activity,
or transfers any major portion of its assets other than in the ordinary course of business; or



 


		(x)	Company breaches in any material respect any covenant
or agreement on its part contained in this Secured Note or any of the other Transaction Documents (as defined in the Credit Agreement);
or



 


		(xi)	Any material inaccuracy or untruthfulness of any representation
or warranty of the Company set forth in this Secured Note, the Credit Agreement or any of the other the Loan Facility Documents
(as defined in the Credit Agreement); or



 




    	A-3



    	 



    

 


		(xii)	There has been an event of default under any of the other
Transaction Documents, as defined therein, which causes a material adverse effect; or



 


		(xiii)	the Company shall default in any of its obligations under
any mortgage, credit agreement or other facility or financing instrument that involves an obligation of the Company of greater
than $100,000 whether such indebtedness now exists or shall hereafter be created; or



 


		(xiv)	the Company has entered against it any monetary judgment,
writ or similar final process for an amount greater than $100,000.



 


8.          
Definitions.


 


“Business Day”
means a day (other than a Saturday or Sunday) on which banks generally are open in New York, New York for the conduct of substantially
all of their activities.


 


“Person”
means any person or entity of any nature whatsoever, specifically including an individual, a firm, a company, a corporation, a
partnership, a limited liability company, a trust or other entity.


 


“Secured Noteholder”
with respect to this Secured Note, means at any time the Persons then the record owner hereof collectively.


 


“Credit Agreement”
means the Credit Agreement, dated March __, 2015 between the Company and the Payee.


 


9.          Expenses
of Enforcement, etc. The Company agrees to pay all reasonable fees and expenses incurred by the Payee in connection with any
amendments, modifications, waivers, extensions, renewals, renegotiations or “workouts” of the provisions hereof or
incurred by the Payee in connection with the enforcement or protection of its rights in connection with this Secured Note, or in
connection with any pending or threatened action, proceeding, or investigation relating to the foregoing, including but not limited
to the reasonable fees and disbursements of counsel for the Payee. The Company indemnifies the Payee and its directors, managers,
affiliates, partners, members, officers, employees and agents against, and agrees to hold the Payee and each such person and/or
entity harmless from, any and all losses, claims, damages, liabilities and related expenses, including reasonable counsel fees
and expenses, incurred by or asserted against the Payee or any such person and/or entity arising out of, in any way connected with,
or as a result of (i) the consummation of the loan evidenced by this Secured Note and the use of the proceeds thereof or (ii) any
claim, litigation, investigation or proceedings relating to any of the foregoing, whether or not the Payee or any such person and/or
entity is a party thereto other than any loss, claim, damage, liability or related expense incurred or asserted against the payee
or any such person on account of the payee’s or such person’s gross negligence or willful misconduct. Notwithstanding
the foregoing, with respect to the indemnification obligations of the Company hereunder, (a) the Company’s aggregate liability
under this Secured Note to the Payee shall not exceed the aggregate principal amount of the Secured Note and (b) indemnified liabilities
shall not include any liability of any indemnitee arising out of such indemnitee’s gross negligence or willful misconduct.
To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum
contribution to the payment and satisfaction of each of the indemnified liabilities which is permissible under applicable law.


 


10.         Security
Interest.


 


(i)          Creation
of Security Interest. In order to secure the payment of the principal and interest and all other obligations of the Company
hereunder now or hereafter owed by the Company to Payee under this Secured Note (the “Secured Obligations”),
the Company and its subsidiary AbTech Industries, Inc. hereby grants to Payee (or its designee) (the “Secured Party”)
a security interest (the “Security Interest”) in all of the tangible and intangible assets of the Company (the
"Collateral"), which includes, without limitation, a security interest in all of the intellectual property held
by the Company and its subsidiaries on the terms and conditions set forth herein and the Transaction Documents.


 


(ii)         Additional
Rights of Secured Party. The Company and its subsidiary AbTech Industries, Inc. shall each execute and deliver to Secured Party
concurrently with the Company’s execution and delivery of this Agreement and at any time thereafter at the reasonable request
of Secured Party, all financing statements, continuation financing statements, fixture filings, security agreements, mortgages,
pledges, assignments, endorsements of certificates of title, applications for title, affidavits, reports, notices, schedules of
accounts, letters of authority, and all other documents that Secured Party may reasonably request, in form reasonably satisfactory
to Secured Party, to perfect and maintain perfected Secured Party’s continuing security interests in the Collateral and in
order to fully consummate all of the transactions contemplated under the Loan Facility Documents, the Company and AbTech Industries,
Inc. hereby authorize Secured Party to file and/or record such financing statements and other documents as Secured Party deems
reasonably necessary to perfect and maintain Secured Party’s continuing security interest in the Collateral, including, but
not limited to, any and all filings recognized by the United States Patent and Trademark Office for the purposes of perfecting
a security interest in any Collateral that is considered intellectual property of the Company. The Company and AbTech Industries,
Inc. each agrees that any such financing statements may contain an “all asset” or “all property” description
of the Collateral.


 




    	A-4



    	 



    

 


(iii)        The
Security Interest shall terminate when all the Secured Obligations have been fully and indefeasibly paid in full, at which time
the Payee shall execute and deliver to the Company and AbTech Industries, Inc. all Uniform Commercial Code termination statements
and similar documents which the Company and/or AbTech Industries, Inc. shall reasonably request to evidence such termination.


 


11.         Amendment
and Waiver. The provisions of this Secured Note may not be modified, amended or waived, and the Company may not take any action
herein prohibited, or omit to perform any act herein required to be performed by it, without the written consent of the holders
of a majority of the then outstanding principal amount of all similar Secured Notes issued in the Company’s offering of Secured
Notes; provided, however, that any waiver of any Event of Default shall require the written consent of the holders
of not less than 60% of the then outstanding principal amount of all similar Secured Notes issued in the Company’s offering
of Secured Notes.


 


12.         Remedies
Cumulative. No remedy herein conferred upon the Payee is intended to be exclusive of any other remedy and each and every such
remedy shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing at law or
in equity or by statute or otherwise.


 


13.         Remedies
Not Waived. No course of dealing between the Company and the Payee or any delay on the part of the Payee in exercising any
rights hereunder shall operate as a waiver of any right of the Payee.


 


14.         Assignments.
The Payee may assign, participate, transfer or otherwise convey this Secured Note and any of its rights or obligations hereunder
or interest herein, in whole or part, to any other Person and this Secured Note shall inure to the benefit of the Payee’s
successors and assigns. The Company shall not assign or delegate this Secured Note or any of its liabilities or obligations hereunder.


 


15.         Headings.
The headings of the sections and paragraphs of this Secured Note are inserted for convenience only and do not constitute a part
of this Secured Note.


 


16.         Severability.
If any provision of this Secured Note is held invalid or unenforceable by any court of competent jurisdiction, the other provisions
of this Secured Note will remain in full force and effect. Any provision of this Secured Note held invalid or unenforceable only
in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.


 


17.         Cancellation.
After all principal, premiums (if any) and accrued interest at any time owed on this Secured Note have been paid in full, or this
Secured Note has been converted this Secured Note will be surrendered to the Company for cancellation and will not be reissued.


 


18.         Maximum
Legal Rate. If at any time an interest rate applicable hereunder exceeds the maximum rate permitted by law, such rate shall
be reduced to the maximum rate so permitted by law.


 


19.         Place
of Payment and Notices. Unless otherwise stated herein, payments of principal and interest are to be delivered to the Secured
Noteholder of this Secured Note at the address provided by the Payee in the Credit Agreement, or at such other address as such
Secured Noteholder has specified by prior written notice to the Company. No notice shall be deemed to have been delivered until
the first Business Day following actual receipt thereof at the foregoing address.


 


20.         Waiver
of Jury Trial. The Payee and the Company each hereby waives any right it may have to a trial by jury in respect of any litigation
directly or indirectly arising out of, under or in connection with this Secured Note and/or the transactions contemplated hereunder.


 


21.         Submission
to Jurisdiction.


 


(i)          Any
legal action or proceeding with respect to this Secured Note may be brought in the courts of the State of New York or of the United
States of America sitting in New York County, and, by execution and delivery of this Secured Note, the Company hereby accepts for
itself and in respect of its property, generally and unconditionally, the jurisdiction of the aforesaid courts.


 




    	A-5



    	 



    

 


(ii)         The
Company hereby irrevocably waives, in connection with any such action or proceeding, any objection, including, without limitation,
any objection to the laying of venue or based on the grounds of forum non conveniens, which they may now or hereafter have to the
bringing of any such action or proceeding in such respective jurisdictions.


 


(iii)        Nothing
herein shall affect the right of the Payee to serve process in any other manner permitted by law or to commence legal proceedings
or otherwise proceed against the Company in any other jurisdiction.


 


22.         GOVERNING
LAW. ALL ISSUES AND QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS SECURED NOTE SHALL
BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW
OR CONFLICT OF LAW RULES OR PROVISIONS (WHETHER OF THE STATE OF NEW YORK OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE APPLICATION
OF THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF NEW YORK.


 


IN WITNESS WHEREOF, the
Company has executed and delivered this Secured Promissory Note on the date first written above.


 


	 	COMPANY:
	 	 
	 	ABTECH HOLDINGS, INC.
	 	 	 
	 	By 	/s/ Glenn R. Rink
	 	Name:	Glenn R. Rink 
	 	Title:	President and CEO


 




    	A-6



    	 



    

 


EXHIBIT B


 


these
securities have not been registered with the united states securities and exchange commission or the securities commission of
any state pursuant to an exemption from registration under regulation d promulgated under the securities act of 1933, as amended
(the “act”). this warrant shall not constitute an offer to sell nor a solicitation of an offer to buy the securities
in any jurisdiction in which such offer or solicitation would be unlawful. the securities are “restricted” and may
not be resold or transferred except as permitted under the act pursuant to registration or exemption therefrom.


 


COMMON STOCK PURCHASE WARRANT


(“Warrant”)


 


To Purchase Shares of $0.001 Par Value Common
Stock (“Common Stock”) of


 


No. [W-__]       [475,000] Shares


 


ABTECH HOLDINGS, INC.


 


THIS CERTIFIES that, for
value received, Golden Properties Ltd (the “Purchaser” or “Holder”) is entitled, upon the
terms and subject to the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to 8:00 p.m.
New York City Time on the date that is five (5) years after the date hereof (the “Termination Date”), but not
thereafter, to subscribe for and purchase from AbTech Holdings Inc., a Nevada corporation (the “Company”), a
number of shares of the Company’s Common Stock set forth above, subject to adjustment as provided herein (such shares, the
“Warrant Shares”) at an initial exercise price of $0.315 per share (the fair market value of the Company’s
Common Stock on the date of issue based on the average closing price of the Company’s Common Stock for the 5 trading days
prior to the date of issue) (as adjusted from time to time pursuant to the terms hereof, the “Exercise Price”).
The Exercise Price and the number of shares for which this Warrant is exercisable shall be subject to adjustment as provided herein.
This Warrant is being issued in connection with the Credit Agreement, dated March 23, 2015 (the “Credit Agreement”),
entered into between the Company and the Purchaser in connection with the Company’s offering a $950,000 Secured Promissory
Note (the “Note”, and such offering, the “Offering”).


 


Capitalized terms used
herein and not otherwise defined shall have the meaning ascribed thereto in the Credit Agreement or the Notes, as applicable.


 


		1.	Title of Warrant. Prior to the expiration hereof
and subject to compliance with applicable laws, this Warrant and all rights hereunder are transferable, in whole or in part, at
the office or agency of the Company by the Holder hereof in person or by duly authorized attorney, upon surrender of this Warrant
together with (a) the Assignment Form annexed hereto properly endorsed, and (b) any other documentation reasonably necessary
to satisfy the Company that such transfer is in compliance with all applicable securities laws. The term “Holder”
shall refer to the Purchaser or any subsequent transferee of this Warrant.



 


		2.	Authorization of Shares. The Company covenants
that all shares of Common Stock which may be issued upon the exercise of rights represented by this Warrant will, upon exercise
of the rights represented by this Warrant and payment of the Exercise Price as set forth herein, be duly authorized, validly issued,
fully paid and nonassessable and free from all taxes, liens and charges in respect of the issue thereof (other than taxes in respect
of any transfer occurring contemporaneously with such issue or otherwise specified herein).



 


		3.	Exercise of Warrant.



 


		a.	The Holder may exercise this Warrant, in whole or in
part, at any time and from time to time by delivering (which may be by facsimile) to the offices of the Company or any transfer
agent for the Common Stock this Warrant, together with a Notice of Exercise in the form annexed hereto specifying the number
of Warrant Shares with respect to which this Warrant is being exercised, together with payment in cash to the Company of the Exercise
Price therefor, or



 




    	B-1



    	 



    

 


		b.	In the event that the Warrant is not exercised in full,
the number of Warrant Shares shall be reduced by the number of such Warrant Shares for which this Warrant is exercised and/or
surrendered, and the Company, if requested by Holder and at its expense, shall within three (3) Trading Days (as defined below)
issue and deliver to the Holder a new Warrant of like tenor in the name of the Holder or as the Holder (upon payment by Holder
of any applicable transfer taxes) may request, reflecting such adjusted Warrant Shares. Notwithstanding anything to the contrary
set forth herein, upon exercise of any portion of this Warrant in accordance with the terms hereof, the Holder shall not be required
to physically surrender this Warrant to the Company unless such Holder is purchasing the full amount of Warrant Shares represented
by this Warrant. The Holder and the Company shall maintain records showing the number of Warrant Shares so purchased hereunder
and the dates of such purchases or shall use such other method, reasonably satisfactory to the Holder and the Company, so as not
to require physical surrender of this Warrant upon each such exercise. The Holder and any assignee, by acceptance of this Warrant
or a new Warrant, acknowledge and agree that, by reason of the provisions of this Section, following exercise of any portion of
this Warrant, the number of Warrant Shares which may be purchased upon exercise of this Warrant may be less than the number of
Warrant Shares set forth on the face hereof. Certificates for shares of Common Stock purchased hereunder shall be delivered to
the Holder hereof within three (3) Trading Days after the date on which this Warrant shall have been exercised as aforesaid. The
Holder may withdraw its Notice of Exercise at any time if the Company fails to timely deliver the relevant certificates to the
Holder as provided in this Agreement. A Notice of Exercise shall be deemed sent on the date of delivery if delivered before 8:00
p.m. New York Time on such date, or the day following such date if delivered after 8:00 p.m. New York Time; provided that the
Company is only obligated to deliver Warrant Shares against delivery of the Exercise Price from the holder hereof and, if the
Holder is purchasing the full amount of Warrant Shares represented by this Warrant, surrender of this Warrant (or appropriate
affidavit and/or indemnity in lieu thereof). In lieu of delivering physical certificates representing the Warrant Shares issuable
upon conversion of this Warrant, provided the Company’s transfer agent is participating in the Depository Trust Company
(“DTC”) Fast Automated Securities Transfer program, upon request of the Holder, the Company shall use its best
efforts to cause its transfer agent to electronically transmit the Warrant Shares issuable upon exercise to the Holder, by crediting
the account of the Holder’s prime broker with DTC through its Deposit Withdrawal At Custodian (“DWAC”)
system. The time periods for delivery described above shall apply to the electronic transmittals through the DWAC system. The
Company agrees to coordinate with DTC to accomplish this objective.



 


		c.	The term “Trading Day” means (x) if
the Common Stock is not listed on the New York or American Stock Exchange but sale prices of the Common Stock are reported on
NASDAQ National Market or another automated quotation system, a day on which trading is reported on the principal automated quotation
system on which sales of the Common Stock are reported, (y) if the Common Stock is listed on the New York Stock Exchange or the
American Stock Exchange, a day on which there is trading on such stock exchange, or (z) if the foregoing provisions are inapplicable,
a day on which quotations are reported by National Quotation Bureau Incorporated. The trading exchange or market on which the
Company’s Common Stock is listed shall be referred to as the “Principal Market”.



 


The Company’s obligations
to issue and deliver Warrant Shares upon an exercise in accordance with Section 3 above are absolute and unconditional, irrespective
of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery
of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination,
or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged
violation of law by the Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such
obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Nothing herein shall limit a Holder’s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares
of Common Stock upon exercise of this Warrant as required pursuant to the terms hereof.


 


		4.	No Fractional Shares or Scrip. No fractional shares
or scrip representing fractional shares shall be issued upon the exercise of this Warrant. In lieu of issuance of a fractional
share upon any exercise hereunder, the Company will either round up to nearest whole number of shares or pay the cash value of
that fractional share, which cash value shall be calculated on the basis of the average closing price of the Common Stock during
the five (5) Trading Days immediately preceding the date of exercise.



 




    	B-2



    	 



    

 


		5.	Charges, Taxes and Expenses. Issuance of certificates
for shares of Common Stock upon the exercise of this Warrant shall be made without charge to the Holder hereof for any issue or
transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall
be paid by the Company, and such certificates shall be issued in the name of the Holder of this Warrant or in such name or names
as may be directed by the Holder of this Warrant; provided, however, that in the event certificates for shares of
Common Stock are to be issued in a name other than the name of the Holder of this Warrant, this Warrant when surrendered for exercise
shall be accompanied by the Assignment Form attached hereto duly executed by the Holder hereof; and provided further,
that the Company shall not be required to pay any tax or taxes which may be payable in respect of any transfer involved in the
issuance of any Warrant certificates or any certificates for the Warrant Shares other than the issuance of a Warrant certificate
to the Holder in connection with the Holder’s surrender of a Warrant Certificate upon the exercise of all or less than all
of the Warrants evidenced thereby.



 


		6.	Closing of Books. The Company will at no time
close its shareholder books or records in any manner which interferes with the timely exercise of this Warrant.



 


		7.	No Rights as Shareholder until Exercise. Subject
to Section 11 of this Warrant and the provisions of any other written agreement between the Company and the Purchaser, the Purchaser
shall not be entitled to vote or receive dividends or be deemed the holder of Warrant Shares or any other securities of the Company
that may at any time be issuable on the exercise hereof for any purpose, nor shall anything contained herein be construed to confer
upon the Purchaser, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors
or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether
upon any recapitalization, issuance of stock, reclassification of stock, change of par value, or change of stock to no par value,
consolidation, merger, conveyance or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights
or otherwise until this Warrant shall have been exercised as provided herein. However, at the time of the exercise of this Warrant
pursuant to Section 3 hereof, the Warrant Shares so purchased hereunder shall be deemed to be issued to such Holder as the record
owner of such shares as of the close of business on the date on which this Warrant shall have been exercised.



 


		8.	Assignment and Transfer of Warrant. This Warrant
may be assigned by the surrender of this Warrant and the Assignment Form annexed hereto duly executed at the office of the Company
(or such other office or agency of the Company or its transfer agent as the Company may designate by notice in writing to the
registered Holder hereof at the address of such Holder appearing on the books of the Company); provided, however,
that this Warrant may not be resold or otherwise transferred except (a) in a transaction registered under the Act, or (b) in a
transaction pursuant to an exemption, if available, from registration under the Act and whereby, if reasonably requested by the
Company, an opinion of counsel reasonably satisfactory to the Company is obtained by the Holder of this Warrant to the effect
that the transaction is so exempt.



 


		9.	Loss, Theft, Destruction or Mutilation of Warrant;
Exchange. The Company represents warrants and covenants that (a) upon receipt by the Company of evidence and/or indemnity
reasonably satisfactory to it of the loss, theft, destruction or mutilation of any Warrant or stock certificate representing the
Warrant Shares, and in case of loss, theft or destruction, of indemnity reasonably satisfactory to it, and (b) upon surrender
and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock
certificate of like tenor and dated as of such cancellation, in lieu of this Warrant or stock certificate, without any charge
therefor. This Warrant is exchangeable at any time for an equal aggregate number of Warrants of different denominations, as requested
by the holder surrendering the same, or in such denominations as may be requested by the Holder following determination of the
Exercise Price. No service charge will be made for such registration or transfer, exchange or reissuance.



 


		10.	Saturdays, Sundays, Holidays, etc. If the last
or appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday, Sunday
or a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day not a legal holiday.



 


		11.	Adjustments of Exercise Price and Number of Warrant
Shares. The number of and kind of securities purchasable upon exercise of this Warrant and the Exercise Price shall be subject
to adjustment from time to time as set forth in this Section 11.



 


		a.	Subdivisions, Combinations, Stock Dividends and other
Issuances. If the Company shall, at any time while this Warrant is outstanding, (i) pay a stock dividend or otherwise make
a distribution or distributions on any equity securities (including instruments or securities convertible into or exchangeable
for such equity securities) in shares of Common Stock (ii) subdivide outstanding shares of Common Stock into a larger number of
shares, or (iii) combine outstanding Common Stock into a smaller number of shares, then the Exercise Price shall be multiplied
by a fraction, the numerator of which shall be the number of shares of Common Stock outstanding before such event and the denominator
of which shall be the number of shares of Common Stock outstanding after such event. Any adjustment made pursuant to this Section
11(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such
dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision or combination.
The number of shares which may be purchased hereunder shall be increased proportionately to any reduction in Exercise Price pursuant
to this paragraph 11(a), so that after such adjustments the aggregate Exercise Price payable hereunder for the increased number
of shares shall be the same as the aggregate Exercise Price in effect just prior to such adjustments.



 




    	B-3



    	 



    

 


		b.	Other Distributions. If at any time after the
date hereof the Company distributes to holders of its Common Stock, other than as part of its dissolution, liquidation or the
winding up of its affairs, any shares of its capital stock, any evidence of indebtedness or any of its assets (other than Common
Stock), then the number of Warrant Shares for which this Warrant is exercisable shall be increased to equal: (i) the number of
Warrant Shares for which this Warrant is exercisable immediately prior to such event, (ii) multiplied by a fraction, (A) the numerator
of which shall be the Fair Market Value (as defined below) per share of Common Stock on the record date for the dividend or distribution,
and (B) the denominator of which shall be the Fair Market Value price per share of Common Stock on the record date for the dividend
or distribution minus the amount allocable to one share of Common Stock of the value (as jointly determined in good faith by the
Board of Directors of the Company and the Holder) of any and all such evidences of indebtedness, shares of capital stock, other
securities or property, so distributed. For purposes of this Warrant, “Fair Market Value” shall equal the
average closing trading price of the Common Stock on the Principal Market for the five (5) Trading Days preceding the date of
determination or, if the Common Stock is not listed or admitted to trading on any Principal Market, and the average price cannot
be determined as contemplated above, the Fair Market Value of the Common Stock shall be as reasonably determined in good faith
by the Company’s Board of Directors and the Holder. If the Fair Market Value of the Common Stock cannot be determined by
the Company’s Board of Directors and the Holder after five (5) business days, such determination shall be made by a third
party appraisal firm mutually agreeable by the Board of Directors and the Holder, at the expense of the Company (the “Independent
Appraiser”). The fair market value as determined by the Independent Appraiser shall be final. The Exercise Price shall
be reduced to equal: (i) the Exercise Price in effect immediately before the occurrence of any event (ii) multiplied by a fraction,
(A) the numerator of which is the number of Warrant Shares for which this Warrant is exercisable immediately before the adjustment,
and (B) the denominator of which is the number of Warrant Shares for which this Warrant is exercisable immediately after the adjustment.



 


		c.	Merger, etc. If at any time after the date hereof
there shall be a merger or consolidation of the Company with or into or a transfer of all or substantially all of the assets of
the Company to another entity, then the Holder shall be entitled to receive upon or after such transfer, merger or consolidation
becoming effective, and upon payment of the Exercise Price then in effect, the number of shares or other securities or property
of the Company or of the successor corporation resulting from such merger or consolidation, which would have been received by
the Holder for the shares of stock subject to this Warrant had this Warrant been exercised just prior to such transfer, merger
or consolidation becoming effective or to the applicable record date thereof, as the case may be. The Company will not merge or
consolidate with or into any other corporation, or sell or otherwise transfer its property, assets and business substantially
as an entirety to another corporation, unless the corporation resulting from such merger or consolidation (if not the Company),
or such transferee corporation, as the case may be, shall expressly assume in writing the due and punctual performance and observance
of each and every covenant and condition of this Warrant to be performed and observed by the Company.



 


		d.	Reclassification, etc. If at any time after the
date hereof there shall be a reorganization or reclassification of the securities as to which purchase rights under this Warrant
exist into the same or a different number of securities of any other class or classes, then the Holder shall thereafter be entitled
to receive upon exercise of this Warrant, during the period specified herein and upon payment of the Exercise Price then in effect,
the number of shares or other securities or property resulting from such reorganization or reclassification, which would have
been received by the Holder for the shares of stock subject to this Warrant had this Warrant at such time been exercised.



 


		e.	Exercise of Extension Option. If at any time after
the date hereof the Company exercises an extension option as described in that certain promissory note entered into in connection
with the Notes and the Credit Agreement, the Warrant Shares issuable hereunder shall be increased by ten percent (10%) for each
such extension option exercised.



 




    	B-4



    	 



    

 


		12.	Voluntary Adjustment by the Company. The Company
may at its option, at any time during the term of this Warrant, reduce but not increase the then current Exercise Price to any
amount and for any period of time deemed appropriate by the Board of Directors of the Company.



 


		13.	Notice of Adjustment. Whenever the number of Warrant
Shares or number or kind of securities or other property purchasable upon the exercise of this Warrant or the Exercise Price is
adjusted, the Company, at its expense, shall promptly mail to the Holder of this Warrant a notice setting forth the number of
Warrant Shares (and other securities or property) purchasable upon the exercise of this Warrant and the Exercise Price of such
Warrant Shares after such adjustment and setting forth the computation of such adjustment and a brief statement of the facts requiring
such adjustment.



 


		14.	Authorized Shares. The Company covenants that
during the period this Warrant is outstanding and exercisable, it will reserve and keep available from its authorized and unissued
Common Stock a sufficient number of shares to provide solely for the issuance of the Warrant Shares upon the exercise of any and
all purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full
authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates
for the Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable
action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable
law, regulation, or rule of any applicable market or exchange.



 


		15.	Compliance with Securities Laws. The Holder hereof
acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered (or if no exemption from registration
exists), will have restrictions upon resale imposed by state and federal securities laws. Each certificate representing the Warrant
Shares issued to the Holder upon exercise (if not registered, for resale or otherwise, or if no exemption from registration exists)
will bear substantially the following legend: THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED WITH THE SECURITIES
AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED, TRANSFERRED, SOLD OR
OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS.



 


		16.	Purpose of Warrant Shares. Without limiting the
Purchaser’s right to transfer, assign or otherwise convey this Warrant or Warrant Shares in compliance with all applicable
securities laws, the Holder of this Warrant, by acceptance hereof, acknowledges that this Warrant and the Warrant Shares to be
issued upon exercise hereof are being acquired solely for the Purchaser’s own account and not as a nominee for any other
party, and that the Purchaser will not offer, sell or otherwise dispose of this Warrant or any Warrant Shares to be issued upon
exercise hereof except under circumstances that will not result in a violation of applicable federal and state securities laws.



 


		17.	Miscellaneous.



 


		a.	Issue Date; Choice of Law; Venue; Jurisdiction.
The provisions of this Warrant shall be construed and shall be given effect in all respects as if it had been issued and delivered
by the Company on the date hereof. This Warrant shall be binding upon any successors or assigns of the Company. This Warrant will
be construed and enforced in accordance with and governed by the laws of the State of New York, except for matters arising under
the Act, without reference to principles of conflicts of law. Each of the parties consents to the exclusive jurisdiction of the
Federal and State Courts sitting in the County of New York in the State of New York in connection with any dispute arising under
this Warrant and hereby waives, to the maximum extent permitted by law, any objection, including any objection based on forum
non conveniens or venue, to the bringing of any such proceeding in such jurisdiction.



 




    	B-5



    	 



    

 


		b.	Modification and Waiver. This Warrant and any
provisions hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against
which enforcement of the same is sought. Any amendment effected in accordance with this paragraph shall be binding upon the Purchaser,
each future holder of this Warrant and the Company. No waivers of, or exceptions to, any term, condition or provision of this
Warrant, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such term,
condition or provision.



 


		c.	Notices. Any notice or other communication required
or permitted to be given hereunder shall be in writing by facsimile, mail or personal delivery and shall be effective upon actual
receipt of such notice. The addresses for such communications shall be to the addresses as shown on the books of the Company or
to the Company at the address set forth in the Loan Facility Documents. A party may from time to time change the address to which
notices to it are to be delivered or mailed hereunder by notice in accordance with the provisions of this Section 9.



 


		d.	Severability. Whenever possible, each provision
of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of
this Warrant is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction,
such invalidity, illegality or unenforceability shall not affect the validity, legality or enforceability of any other provision
of this Warrant in such jurisdiction or affect the validity, legality or enforceability of any provision in any other jurisdiction,
but this Warrant shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision
had never been contained herein.



 


		e.	Specific Enforcement. The Company and the Holder
acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Warrant were not performed
in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled
to an injunction or injunctions to prevent or cure breaches of the provisions of this Warrant and to enforce specifically the
terms and provisions hereof, this being in addition to any other remedy to which either of them may be entitled by law or equity.



 


		f.	Counterparts/Execution. This Warrant may be executed
by facsimile and in any number of counterparts, and each such counterpart hereof shall be deemed to be an original instrument,
but all such counterparts together shall constitute one agreement. Execution and delivery of this Warrant by facsimile transmission
(including delivery of documents in Adobe PDF format) shall constitute execution and delivery of this Warrant for all purposes,
with the same force and effect as execution and delivery of an original manually signed copy hereof.



 


IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officers thereunto duly authorized.


 


Dated: March 23, 2015


 


	 	ABTECH HOLDINGS, INC.
	 	 	 
	 	By: 	/s/ Glenn R. Rink
	 	Name:  	Glenn R. Rink
	 	Title:	President and CEO


 




    	B-6



    	 



    

 


NOTICE OF EXERCISE


 


		To:	ABTECH HOLDINGS, INC.



 


The undersigned hereby
irrevocably exercises the right to purchase _______________ shares of Common Stock of AbTech Holdings Inc., a Nevada corporation,
evidenced by the attached Warrant, and tenders herewith payment of the aggregate Exercise Price with respect to such shares in
full, in the amount of $__________, in cash, by certified or official bank check or by wire transfer for the account of the Company.


 


The undersigned requests
that stock certificates for such Warrant Shares be issued, and a Warrant representing any unexercised portion hereof be issued,
pursuant to this Warrant, in the name of the registered Warrant Holder and delivered to the undersigned at the address set forth
below.


 


	 	 
	 	(Name)
	 	 
	 	 
	 	(Signature)
	 	 
	 	 
	 	(Address)


 


	 	 
	Signature	 
	 	 	 
	Date:	 	 


 




    	B-7



    	 



    

 


ASSIGNMENT FORM


 


(To assign the foregoing warrant, execute


this form and supply required information.


Do not use this form to exercise the warrant.)


 


FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to


 


_______________________________________________
whose address is


 


_______________________________________________________________.


 


_______________________________________________________________


 


	 	 	Dated:  ______________,
	 	 	 
	 	Holder’s Signature:	_____________________________
	 	 	 
	 	Holder’s Address:	_____________________________
	 	 	 
	 	 	_____________________________


 


Signature Guaranteed: ___________________________________________


 


NOTE: The signature to this Assignment Form
must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever,
and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative
capacity should file proper evidence of authority to assign the foregoing Warrant.


 




    	B-8



    	 



    

 


EXHIBIT C


 


INVESTOR QUESTIONNAIRE


 


ABTECH HOLDINGS, INC.


 


Confidential Investor Questionnaire


 


To:AbTech Holdings, Inc.


 


I.           The
Investor represents and warrants that he or it comes within one category marked below, and that for any category marked,
he or it has truthfully set forth, where applicable, the factual basis or reason the Investor comes within that category. ALL INFORMATION
IN RESPONSE TO THIS SECTION WILL BE KEPT STRICTLY CONFIDENTIAL EXCEPT AS NECESSARY FOR THE COMPANY AND/OR THE PLACEMENT AGENT TO
COMPLY WITH LAW AND/OR ANY RULES PROMULGATED BY ANY REGULATORY AGENCY. The undersigned shall furnish any additional information
which the Company deems necessary in order to verify the answers set forth below.


 


Category
A __                  The undersigned is an individual (not a partnership, corporation, etc.) whose individual net worth, or joint net worth
with his or her spouse, presently exceeds $1,000,000, excluding the value of the primary residence of such individual, calculated
by subtracting from the estimated fair market value of the property the amount of debt secured by the property, up to the estimated
fair market value of the property.


 


Explanation. In calculating
net worth you may include equity in personal property and real estate (other than Investor’s principal residence which may
not be included in such net worth calculation), cash, short-term investments, stock and securities. Equity in personal property
and real estate should be based on the fair market value of such property less debt secured by such property.


 


Category
B __                 The undersigned is an individual (not a partnership, corporation, etc.) who had an individual income in excess of $200,000
in each of the two most recent years, or joint income with his or her spouse in excess of $300,000 in each of those years (in each
case including foreign income, tax exempt income and full amount of capital gains and losses but excluding any income of other
family members and any unrealized capital appreciation) and has a reasonable expectation of reaching the same income level in the
current year.


 


Category
C __                 The undersigned is a director or executive officer of the Company which is issuing and selling the Secured Promissory
Notes (“Notes”).


 


Category
D __               The undersigned is a bank; a savings and loan association; insurance company; registered investment company; registered
business development company; licensed small business investment company; or employee benefit plan within the meaning of Title
1 of ERISA and (a) the investment decision is made by a plan fiduciary which is either a bank, savings and loan association, insurance
company or registered investment advisor, or (b) the plan has total assets in excess of $5,000,000 or is a self directed plan with
investment decisions made solely by persons that are accredited investors.


 


	 	 
	 	 
	 	(describe entity)


 


Category
E __                   The undersigned is a private business development company as defined in section 202(a)(22) of the Investment Advisors
Act of 1940.


 


	 	 
	 	 
	 	(describe entity)


 




    	C-1



    	 



    

 


Category
F __                The undersigned is either a corporation, partnership, Massachusetts business trust, or non-profit organization within
the meaning of Section 501(c)(3) of the Internal Revenue Code, in each case not formed for the specific purpose of acquiring the
Notes and with total assets in excess of $5,000,000.


 


	 	 
	 	 
	 	(describe entity)


 


Category
G __               The undersigned is a trust with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring
the Notes, where the purchase is directed by a “sophisticated person” as defined in Regulation 506(b)(2)(ii) under
the Securities Act of 1933.


 


Category
H __                The undersigned is an entity (other than a trust) all the equity owners of which are “accredited investors”
within one or more of the above categories. If relying upon this Category alone, each equity owner must complete a separate copy
of this Agreement.


 


	 	 
	 	 
	 	(describe entity)


 


Category
I __                The undersigned is not within any of the categories above and is therefore not an accredited investor.


 


For purposes hereof, “individual income”
means adjusted gross income less any income attributable to a spouse or to property owned by a spouse, increased by the following
amounts (but not including any amounts attributable to a spouse or to property owned by a spouse): (i) the amount of any interest
income received which is tax-exempt under Section 103 of the Internal Revenue Code of 1986, as amended (the “Code”),
(ii) the amount of losses claimed as a limited partner in a limited partnership (as reported on Schedule E of Form 1040), (iii)
any deduction claimed for depletion under Section 611 et seq. of the Code, and (iv) any amount by which income from long-term capital
gains has been reduced in arriving at adjusted gross income pursuant to the provisions of Section 12.02 of the Code.


 


The undersigned agrees that the undersigned
will notify the Company at any time on or prior to the execution of this Agreement in the event that the representations and warranties
in this Agreement shall cease to be true, accurate and complete.


 


II.          SUITABILITY
(please answer each question)


 


(a)          For
an individual Investor, please describe your current employment, including the company by which you are employed and its principal
business:


________________________________________________________________________________________________


________________________________________________________________________________________________


________________________________________________________________________________________________


________________________


 


(b)          For
an individual Investor, please describe any college or graduate degrees held by you:


________________________________________________________________________________________________


________________________________________________________________________________________________


_________________________________________


 


(c)          For
all Investors, please list types of prior investments:


______________________________________________________________________________


________________________________________________________________________________________________


________________________________________________________________________________________________


__________________________________________


 


(d)          For
all Investors, please state whether you have you participated in other private placements before:


 


YES_______                                NO_______


 


(e)          If
your answer to question (d) above was “YES”, please indicate frequency of such prior participation in private placements
of:


 




    	C-2



    	 



    

 


	 	Public	Private
	 	Companies	Companies
	 	 	 
	Frequently	___________	__________________
	Occasionally	___________	__________________
	Never	___________	__________________


 


(f)          For
individual Investors, do you expect your current level of income to significantly decrease in the foreseeable future:


YES_______                                NO_______


 


(g)          For
trust, corporate, partnership and other institutional Investors, do you expect your total assets to significantly decrease in the
foreseeable future:


YES_______                                NO_______


 


(h)          For
all Investors, do you have any other investments or contingent liabilities which you reasonably anticipate could cause you to need
sudden cash requirements in excess of cash readily available to you:


YES_______                                NO_______


 


(i)          For
all Investors, are you familiar with the risk aspects and the non-liquidity of investments such as the Notes for which you seek
to subscribe?


YES_______                                NO_______


 


(j)          For
all Investors, do you understand that there is no guarantee of financial return on this investment and that you run the risk of
losing your entire investment?


YES_______                                NO_______


 


III.         MANNER
IN WHICH TITLE IS TO BE HELD. (circle one)


 


(a)          Individual
Ownership


(b)          Community
Property


(c)          Joint
Tenant with Right of Survivorship (both parties must sign)


(d)          Partnership*


(e)          Tenants
in Common


(f)           Corporation*


(g)          Trust*


(h)          Limited
Liability Company*


(i)           Other


 


*If Notes are being subscribed for
by an entity, the attached Certificate of Signatory must also be completed.


 


IV.          FINRA
AFFILIATION.


 


Are you affiliated or associated with an FINRA
member firm (please check one):


 


Yes _________          No
__________


 


If Yes, please describe:


_________________________________________________________


_________________________________________________________


_________________________________________________________


 


*If Investor is a Registered Representative
with an FINRA member firm, have the following acknowledgment signed by the appropriate party:


 


The undersigned FINRA member firm acknowledges
receipt of the notice required by Rule 3050 of the NASD Conduct Rules.


_________________________________


Name of FINRA Member Firm


 




    	C-3



    	 



    

 


By: ______________________________


Authorized Officer


 


Date: ____________________________


 


V.          The undersigned is informed of the significance
to the Company of the foregoing representations and answers contained in the Confidential Investor Questionnaire contained herein
and such answers have been provided under the assumption that the Company will rely on them.


 


VI.          In
furnishing the above information, the undersigned acknowledges that the Company will be relying thereon in determining, among other
things, whether there are reasonable grounds to believe that the undersigned qualifies as a Purchaser under Section 4(2) and/or
Regulation D of the Securities Act of 1933 and applicable State Securities laws for the purposes of the proposed investment.


 


VII.         The
undersigned understands and agrees that the Company may request further information of the undersigned in verification or amplification
of the undersigned’s knowledge of business affairs, the undersigned’s assets and the undersigned’s ability to
bear the economic risk involved in an investment in the securities of the Company.


 


VIII.         The
undersigned represents to you that (a) the information contained herein is complete and accurate on the date hereof and may be
relied upon by you and (b) the undersigned will notify you immediately of any change in any such information occurring prior to
the acceptance of the subscription and will promptly send you written confirmation of such change. The undersigned hereby certifies
that he, she or it has read and understands the Credit Agreement related hereto.


 


IX.          In
order for the Company to comply with applicable anti-money laundering/U.S. Treasury Department Office of Foreign Assets Control
(“OFAC”) rules and regulations, Investor is required to provide the following information:


 


1.          Payment
Information


 


(a)       Name
and address (including country) of the bank from which Investor’s payment to the Company is being wired (the “Wiring
Bank”):


_______________________________________


_______________________________________


_______________________________________


_______________________________________


 


(b)       Investor’s
wiring instructions at the Wiring Bank:


_______________________________________


_______________________________________


_______________________________________


 


(c)       Is
the Wiring Bank located in the U.S. or another “FATF Country”*?


 


_____ Yes         ______
No


 


(d)       Is
Investor a customer of the Wiring Bank?


_____ Yes         ______
No


 


2.          Additional
Information


 


For Individual Investors:


 


____ A government issued form of picture identification
(e.g., passport or drivers license).


 





 



* As of the date hereof, countries
that are members of the Financial Action Task Force on Money Laundering (“FATF Country”) are: Argentina, Australia,
Austria, Belgium, Brazil, Canada, Denmark, Finland, France, Germany, Greece, Hong Kong, Iceland, Ireland, Italy, Japan, Luxembourg,
Mexico, Kingdom of the Netherlands, New Zealand, Norway, Portugal, Russian Federation, Singapore, South Africa, Spain, Sweden,
Switzerland, Turkey, United Kingdom and the United States of America.


 




    	C-4



    	 



    

 


____ Proof of the individual’s current address
(e.g., current utility bill), if not included in the form of picture identification.


 


For Funds of Funds or Entities that Invest on Behalf
of Third Parties:


 


		_____	A certificate of due formation and organization and continued authorization to conduct business
in the jurisdiction of its organization (e.g., certificate of good standing).



 


		_____	An “incumbency certificate” attesting to the title of the individual executing these
subscription materials on behalf of the prospective investor.



 


		_____	A completed copy of a certification that the entity has adequate anti-money laundering policies
and procedures (“AML Policies and Procedures”) in place that are consistent with the USA PATRIOT Act, OFAC and
other relevant federal, state or non-U.S. anti-money laundering laws and regulations (with a copy of the entity’s current
AML Policies and Procedures to which such certification relates).



 


		_____	A letter of reference any entity not located in the U.S. or other FATF country, from the entity’s
local office of a reputable bank or brokerage firm that is incorporated, or has its principal place of business located, in the
U.S. or other FATF Country certifying that the prospective investor maintains an account at such bank/brokerage firm for a length
of time and containing a statement affirming the prospective investor’s integrity.



 


For all other Entity Investors:


 


		_____	A certificate of due formation and organization and continued authorization to conduct business
in the jurisdiction of its organization (e.g., certificate of good standing).



 


		_____	An “incumbency certificate” attesting to the title of the individual executing these
subscription materials on behalf of the prospective investor.



 


		_____	A letter of reference from the entity’s local office of a reputable bank or brokerage firm
that is incorporated, or has its principal place of business located, in the U.S. or other FATF Country certifying that the prospective
investor maintains an account at such bank/brokerage firm for a length of time and containing a statement affirming the prospective
investor’s integrity.



 


		_____	If the prospective investor is a privately-held entity, a certified list of the names of every
person or entity who is directly or indirectly the beneficial owner of 25% or more of any voting or non-voting class of equity
interests of the Investor, including (i) country of citizenship (for individuals) or principal place of business (for entities)
and, (ii) for individuals, such individual’s principal employer and position.



 


		_____	If the prospective investor is a trust, a certified list of (i) the names of the current beneficiaries
of the trust that have, directly or indirectly, 25% or more of any interest in the trust, (ii) the name of the settlor of the trust,
(iii) the name(s) of the trustee(s) of the trust, and (iv) the country of citizenship (for individuals) or principal place of business
(for entities).



 


X.           ADDITIONAL
INFORMATION.


 


A TRUST MUST ATTACH A COPY
OF ITS DECLARATION OF TRUST OR OTHER GOVERNING INSTRUMENT, AS AMENDED, AS WELL AS ALL OTHER DOCUMENTS THAT AUTHORIZE THE TRUST
TO INVEST IN THE SECURITIES. ALL RESOLUTIONS AND DOCUMENTATION MUST BE COMPLETE AND CORRECT AS OF THE DATE HEREOF.


 




    	C-5



    	 



    

 


XI.          INFORMATION
VERIFICATION CONSENT.


 


BY
SIGNING THIS SUBSCRIPTION AGREEMENT, SUBSCRIBER HEREBY GRANTS THE PLACEMENT AGENT PERMISSION TO REVIEW ALL PUBLICLY AVAILABLE INFORMATION
REGARDING SUBSCRIBER, INCLUDING, BUT NOT LIMITED TO INFORMATION PROVIDED BY The Office of Foreign Assets Control (“OFAC”)
FOR THE PURPOSE OF VERIFYING INFORMATION PROVIDED BY SUBSCRIBER HEREIN.


 


	 	 	 
	Signature	 	Signature (if purchasing jointly)
	 	 	 
	 	 	 
	Name Typed or Printed	 	Name Typed or Printed
	 	 	 
	 	 	 
	Entity Name	 	Entity Name
	 	 	 
	 	 	 
	Address	 	Address
	 	 	 
	 	 	 
	City, State and Zip Code	 	City, State and Zip Code


 




    	C-6



    	 



    

 


EXHIBIT
D


 


RISK FACTORS


 


An investment in this Offering is extremely
risky. You should carefully consider the risks, in addition to the other information presented in this Memorandum before deciding
to purchase the Securities being offered by AbTech Holdings Inc. If any of the following risks actually materialize, our business
and prospects could be seriously harmed and you could lose all or part of your investment. The risks and uncertainties described
below are not exclusive and investors should also review the Company’s public filings. The Company’s ticker symbol
is (OTCBB: ABHD).


 


Risks Relating to this Offering


 


No Anti-dilution protection


 


The Notes and Warrants contain no anti-dilution
provisions, which means that the Company can issue additional shares of common stock and that such additional issuances will have
a dilutive effect on the Secured Notes and Warrants issued in this Offering.


 


Use of Proceeds of this Offering


 


Our management will have considerable discretion
in how we use the net proceeds from this Offering, and no representation can be made that use of proceeds will generate material
revenues or materially improve our ability to further develop our product. We intend to use the net proceeds for working capital,
general corporate purposes and for the repayment of certain indebtedness. Even if we generate material revenues, we currently plan
to seek additional capital following this Offering. No assurance can be given that any source of additional cash will be available
to us. If no source of additional cash is available to us, we may have to significantly reduce the scope of our operations.


 


No Independent Valuation 


 


The Company has not obtained an independent
opinion regarding the valuation of the Company or the Securities, nor has there been any legal, investment banking, or other diligence
in connection with the valuation of the Company or the Securities. Prospective investors must rely on their own business and investment
background and their own investigation of the Company and its proposed business in determining whether to invest in the Company
and the Secured Notes.


 


Private Offering Exemption


 


This Offering is being made in reliance on
an exemption from registration contained in the Securities Act and the rules and regulations thereunder, and on similar exemptions
from the qualification provisions of applicable state securities laws. No regulatory authority has reviewed the terms of this Offering,
the disclosure of risks and the fairness of the terms of the Offering or the business of the Company. Prospective investors must
also recognize that they do not necessarily have any of the protections afforded by applicable federal and state securities laws
as may be provided in registered and/or qualified offerings and therefore must judge the fairness of the terms of this Offering
and the adequacy and accuracy of this Memorandum without the benefit of prior review by any regulatory agency.


 


Transaction Fees & Expenses


 


This Offering involves substantial fees and
expenses which will be paid out of the proceeds of the Offering thus reducing the amount of proceeds available to the Company.


 


Risks Relating to Our
Business


 


Our ability to generate revenue to support
our operations is uncertain.


 


We are in the early stage
of our business and have a limited history of generating revenues. We have a limited operating history upon which you can evaluate
our potential for future success, and we are subject to the additional risks affecting early-stage businesses. Rather than relying
on historical information, financial or otherwise, to evaluate our Company, you should evaluate our Company in light of your assessment
of the growth potential of our business and the expenses, delays, uncertainties, and complications typically encountered by early-stage
businesses, many of which will be beyond our control. Early-stage businesses in rapidly evolving markets commonly face risks, such
as the following:


 




    	D-1



    	 



    

 


•            unanticipated
problems, delays, and expenses relating to the development and implementation of their business plans;


•            operational difficulties;


•            lack of sufficient
capital;


•            competition from
more advanced enterprises; and


•            uncertain revenue
generation.


 


Our limited operating history may make it
difficult for us to forecast accurately our operating results.


 


Our planned expense levels
are, and will continue to be, based in part on our expectations, which are difficult to forecast accurately based on our stage
of development and factors outside of our control. We may be unable to adjust spending in a timely manner to compensate for any
unexpected developments. Further, business development expenses may increase significantly as we expand operations. To the extent
that any unexpected expenses precede, or are not rapidly followed by, a corresponding increase in revenue, our business, operating
results, and financial condition may be materially and adversely affected.


 


We have a history of losses that may continue,
which may negatively impact our ability to achieve our business objectives.


 


We have incurred net losses
since our inception. We cannot assure you that we can achieve or sustain profitability on a quarterly or annual basis in the future.
There can be no assurance that future operations will be profitable. We may not achieve our business objectives and the failure
to achieve such goals would have an adverse impact on us.


 


Our success depends on our ability to expand,
operate, and manage successfully our operations.


 


Our success depends on
our ability to expand, operate, and manage successfully our operations. Our ability to expand successfully will depend upon a number
of factors, including the following:


 


•            signing with
strategic partners, dominant in their field


•            the continued
development of our business;


•            the hiring, training,
and retention of additional personnel;


•            the ability to
enhance our operational, financial, and management systems;


•            the availability
of adequate financing;


•            competitive factors;


•            general economic
and business conditions; and


•            the ability to
implement methods for revenue generation.


 


If we are unable to obtain additional capital,
our business operations could be harmed.


 


The development and expansion
of our business will require additional funds. In the future, we expect to seek additional equity or debt financing to provide
capital for our Company. Such financing may not be available or may not be available on satisfactory terms. If financing is not
available on satisfactory terms, we may be unable to expand our operations. While debt financing will enable us to expand our business
more rapidly than we otherwise would be able to do, debt financing increases expenses and we must repay the debt regardless of
our operating results. Future equity financings could result in dilution to our stockholders.


 


The recent global financial
crisis, which has included, among other things, significant reductions in available capital and liquidity from banks and other
providers of credit, substantial reductions or fluctuations in equity and currency values worldwide, and concerns that the worldwide
economy may enter into a prolonged recessionary period, may make it difficult for us to raise additional capital or obtain additional
credit, when needed, on acceptable terms or at all.


 


Our inability to obtain
adequate capital resources, whether in the form of equity or debt, to fund our business and growth strategies, may require us to
delay, scale back, or eliminate some or all of our operations, which may adversely affect our financial results and ability to
operate as a going concern.


 




    	D-2



    	 



    

 


You may suffer significant dilution if we
raise additional capital.


 


If we raise additional
capital, we expect it will be necessary for us to issue additional equity or convertible debt securities. If we issue equity or
convertible debt securities, the price at which we offer such securities may not bear any relationship to our value, the net tangible
book value per share may decrease, the percentage ownership of our current stockholders would be diluted, and any equity securities
we may issue in such offering or upon conversion of convertible debt securities issued in such offering, may have rights, preferences,
or privileges with respect to liquidation, dividends, redemption, voting, and other matters that are senior to or more advantageous
than our common stock.


 


If we obtain debt financing, we will face
risks associated with financing our operations.


 


If we obtain debt financing,
we will be subject to the normal risks associated with debt financing, including the risk that our cash flow will be insufficient
to meet required payments of principal and interest and the risk that we will not be able to renew, repay, or refinance our debt
when it matures or that the terms of any renewal or refinancing will not be as favorable as the existing terms of that debt. If
we enter into secured lending facilities and are unable to pay our obligations to our secured lenders, they could proceed against
any or all of the collateral securing our indebtedness to them.


 


Our independent auditors have expressed
substantial doubt about its ability to continue as a going concern, which may hinder our ability to obtain future financing. 



 


In their report dated March
29, 2013, our independent auditors stated that our financial statements for the fiscal year ended December 31, 2012 were prepared
assuming that the Company would continue as a going concern. Its ability to continue as a going concern is an issue raised as a
result of recurring losses from operations. Our ability to continue as a going concern is subject to our ability to obtain necessary
funding from outside sources, including obtaining additional funding from the sale of our securities. Our continued net operating
losses increase the difficulty in meeting such goals and there can be no assurances that such methods will prove successful.


 


We depend on our officers and key employees
who would be difficult to replace, and our business will likely be harmed if we lose their services or cannot hire additional qualified
personnel.


 


Our success depends substantially
on the efforts and abilities of our officers and other key employees. AbTech Industries has employment agreements with its chief
executive officer, its chief financial officer, and certain key employees, but we do not think those agreements limit any employee’s
ability to terminate his or her employment. We have key person life insurance on Glenn R. Rink, our president, chief executive
officer and a director; we do not have key person life insurance covering any of our other officers or other key employees. The
loss of services of one or more of our officers or key employees or the inability to add key personnel could have a material adverse
effect on our business. Competition for experienced personnel in our industry is substantial. Our success depends in part on our
ability to attract, hire, and retain qualified personnel. In addition, if any of our officers or other key employees join a competitor
or form a competing company, we may lose some of our customers.


 


We depend on the recruitment and retention
of qualified personnel, and our failure to attract and retain such personnel could seriously harm our business.


 


Due to the specialized
nature of our business, our future performance is highly dependent upon the continued services of current and future key personnel
and managers. Our future business depends upon our ability to attract and retain qualified engineering, manufacturing, marketing,
sales, and management personnel for our operations. We may also have to compete with the other companies in our industry in the
recruitment and retention of qualified managerial and technical employees. Competition for personnel is intense and confidentiality
and non-compete agreements may restrict our ability to hire individuals employed by other companies. Therefore, we may not be successful
in attracting or retaining qualified personnel. Our failure to attract and retain qualified personnel could seriously harm our
business, results of operations, and financial condition. Furthermore, we may not be able to accurately forecast our needs for
additional personnel, which could adversely affect our ability to grow.


 


The effects of the recent global economic
downturn may adversely impact our business, operating results, or financial condition. 


 


The recent global economic
downturn has caused disruptions and volatility in global financial markets and increased rates of default and bankruptcy and has
impacted levels of consumer and commercial spending. We are unable to predict the duration or severity of the current global economic
and financial crisis. There can be no assurance that any actions we may take in response to further deterioration in general economic
and financial conditions will be sufficient. A protracted continuation or worsening of the global economic downturn or disruptions
in the financial markets could have a material adverse effect on our business, financial condition, or results of operations.


 




    	D-3



    	 



    

 


If we do not achieve broad market acceptance
of our clean technology products and services, we may not be successful.


 


Although our clean technology
products and services will serve existing needs, our delivery of these products and services is unique and subject to broad market
acceptance. As is typical of any new product or service, the demand for and market acceptance of these products and services are
highly uncertain. We cannot assure you that any of our products and services will be commercialized on a widespread basis. The
commercial acceptance of our products and services may be affected by a number of factors, including the willingness of municipalities
and other commercial and industrial entities to use our clean technology products and services to control the quality of water
and other fluids. If the markets for our products and services fail to develop on a meaningful basis, if they develop more slowly
than we anticipate, or if our products and services fail to achieve sufficient market acceptance, our business and future results
of operations could be adversely affected.


 


Because our clean technology products may
be designed to provide a solution which competes with existing methods, we are likely to face resistance to change, which could
impede our ability to commercialize this business.


 


Our clean technology products
may be designed to provide a solution to environmental challenges created by contaminated water and other fluids. Currently, large
and well capitalized companies provide services in these areas. These competitors have strong relationships with their customers’
personnel, and there is a natural reluctance for businesses to change to new technologies, particularly in such industries as the
oil and gas industries where our future products may be relevant. This reluctance is increased when potential customers make significant
capital investments in competing technologies. Because of these obstacles, we may face substantial barriers to commercializing
our business.


 


If we experience rapid growth and we are
not able to manage this growth successfully, this inability to manage the growth could adversely affect our business, financial
condition, and results of operations.


 


Rapid growth places a significant
strain on our financial, operational, and managerial resources. While we engage in strategic and operational planning to adequately
manage anticipated growth, there can be no assurance that we will be able to implement and subsequently improve operations and
financial systems successfully and in a timely manner to fully manage our growth. There can be no assurance that we will be able
to manage our growth and any inability to successfully manage growth could materially adversely affect our business, financial
condition, and results of operation.


 


We have no experience in manufacturing or
assembling products on a large scale basis, and if we do not develop adequate manufacturing and assembly processes and capabilities
to do so in a timely manner, we may be unable to achieve our growth and profitability objectives.


 


We have no experience manufacturing
or assembling products on a large scale. We do not know whether our current or future manufacturing arrangements will be able to
develop efficient, low-cost manufacturing capabilities and processes that will enable us to meet the quality, price, engineering,
design and production standards, or production volumes required to successfully mass market such products. Even if we are successful
in developing manufacturing capabilities and processes, we do not know whether we will do so in time to meet our product commercialization
schedule or to satisfy the requirements of our target market. Our failure to develop these manufacturing processes and capabilities,
if necessary, in a timely manner could prevent us from achieving our growth and profitability objectives.


 


If we fail to continue to develop or acquire
new products, adapt to rapid and significant technological change, and respond to introductions of new products, we will not be
competitive.


 


Our growth strategy includes
significant investment in and expenditures for product development. We intend to sell clean technology products, primarily in the
water clean-up sector, which are characterized by rapid and significant technological changes, frequent new product and service
introductions, and enhancements and evolving industry standards. Without the timely introduction of new products, services, and
enhancements, our products and services may become technologically obsolete over time, in which case our revenue and operating
results would suffer.


 




    	D-4



    	 



    

 


In addition, our competitors
may adapt more quickly to new technologies and changes in customers’ requirements than we can. The products that we are currently
developing or those that we will develop in the future, may not be technologically feasible or accepted by the marketplace, and
our products or technologies could become uncompetitive or obsolete.


 


The market for our products is highly competitive,
and there can be no assurance that competitors will not emerge in the near to medium term with comparable products or technologies.



 


The markets for our products
and services are expected to remain highly competitive. While we believe our products are unique and have, or will have, adequate
patent protection for the underlying technologies, or unique trade secrets, there can be no assurance that competitors will not
emerge in the near to medium term with comparable products or technologies. There are a number of large companies involved in the
same businesses as us, but with larger more established sales and marketing organizations, technical staff, and financial resources.
We may establish marketing and distribution partnerships or alliances with some of these companies, but there can be no assurance
that such alliances will be formed.


 


Our business may become substantially dependent
on contracts that are awarded through competitive bidding processes.


 


We may sell a significant
portion of our products pursuant to contracts that are subject to competitive bidding, including contracts with municipal authorities.
Competition for, and negotiation and award of, contracts present varied risks, including, but not limited to:


 


•            investment of
substantial time and resources by management for the preparation of bids and proposals with no assurance that a contract will be
awarded to us;


•            the requirement
to certify as to compliance with numerous laws (for example, socio-economic, small business, and domestic preference) for which
a false or incorrect certification can lead to civil and criminal penalties;


•            the need to estimate
accurately the resources and cost structure required to service a contract; and


•            the expenses
and delays that we might suffer if our competitors protest a contract awarded to us, including the potential that the contract
may be terminated and a new bid competition may be conducted.


 


If we are unable to win
contracts awarded through the competitive bidding process, we may not be able to operate in the market for products and services
that are provided under those contracts for a number of years. If we are unable to consistently win new contract awards over any
extended period, or if we fail to anticipate all of the costs and resources that will be required to secure and perform such contract
awards, our growth strategy and our business, financial condition, and results of operations could be materially and adversely
affected.


 


We will sell products and services to companies
in industries which tend to be extremely cyclical; downturns in those industries would adversely affect our results of operations.


 


The growth and profitability
of our business will depend on sales to industries that are subject to cyclical downturns. Slowdowns in these industries may adversely
affect sales by our businesses, which in turn would adversely affect our revenues and results of operations. In particular, our
products may be sold to and used by the oil and gas industry, which historically has realized significant shifts in activity and
spending due to fluctuations in commodity prices. Our revenues may be dependent upon spending by oil and gas producers; therefore,
a reduction in spending by producers may have a materially adverse effect on our business, financial conditions, and results of
operations.


 


The industries in which we may sell our
products are heavily regulated and costs associated with such regulation could reduce our profitability. 


 


Federal, state, and local
authorities extensively regulate the stormwater and oil and gas industries, which are primary industries in which we may sell our
products and offer our services. Legislation and regulations affecting the industries are under constant review for amendment or
expansion. State and local authorities regulate various aspects of stormwater and oil and gas activities that ultimately affect
how customers use our products and how we develop and market our products. The overall regulatory burden on the industries increases
the cost of doing business, which, in turn, decreases profitability.


 


International sales are
also subject to rules and regulations promulgated by regulatory bodies within foreign jurisdictions, and there can be no assurance
that such foreign regulatory bodies will not adopt laws or regulatory requirements that could adversely affect our Company.


 




    	D-5



    	 



    

 


If chemical companies engage in predatory
pricing, we may lose customers, which could materially and adversely affect us.


 


Municipalities and other
commercial and industrial entities traditionally have used chemicals to control the quality of water and other fluids. The chemical
companies represent a significant competitive factor. The chemical companies who supply chemicals to such municipalities and other
commercial and industrial entities may, in order to maintain their business relationship, drastically reduce their price and seek
to undercut the pricing at which we can realistically charge for our products and services. While predatory pricing that is designed
to drive us out of business may be illegal under the United States anti-trust and other laws, we may lose customers as a result
of any future predatory pricing and be required to file lawsuits against any companies who engage in such improper tactics. Any
such litigation may be very expensive which will further impact us and affect their financial condition. As a result, predatory
pricing by chemical companies could materially and adversely affect us.


 


We are, or in the future may be, subject
to substantial regulation related to quality standards applicable to our manufacturing and quality processes. Our failure to comply
with applicable quality standards could have an adverse effect on our business, financial condition, or results of operations.


 


The Environmental Protection
Agency regulates the registration, manufacturing, and sales and marketing of products in our industry, and those of our distributors
and partners, in the United States. Significant government regulation also exists in overseas markets. Compliance with applicable
regulatory requirements is subject to continual review and is monitored through periodic inspections and other review and reporting
mechanisms.


 


Failure by us or our partners
to comply with current or future governmental regulations and quality assurance guidelines could lead to temporary manufacturing
shutdowns, product recalls or related field actions, product shortages, or delays in product manufacturing. Efficacy or safety
concerns and/or manufacturing quality issues with respect to our products or those of our partners could lead to product recalls,
fines, withdrawals, declining sales, and/or our failure to successfully commercialize new products or otherwise achieve revenue
growth.


 


If a natural or man-made disaster strikes
our or a third-party’s manufacturing facility that we may use, we may be unable to manufacture our products for a substantial
amount of time and our sales and profitability will decline.


 


The manufacturing facility
and manufacturing equipment we will use to produce our products will be costly to replace and could require substantial lead-time
to repair or replace. Our facility or a third-party’s facility that we use may be affected by natural or man-made disasters.
In the event they were affected by a disaster, we would be forced to set up alternative production capacity, or rely on third-party
manufacturers to whom we would have to disclose our trade secrets. Although we intend to possess insurance for damage to our property
and the disruption of our business from casualties, such insurance may not be sufficient to cover all of our potential losses,
may not continue to be available to us on acceptable terms, or at all, and may not address the marketing and goodwill consequences
of our inability to provide products for an extended period of time.


 


We may decide to outsource manufacturing
in the future. Dependence on contract manufacturing and outsourcing other portions of our supply chain may adversely affect our
ability to bring products to market and damage our reputation. 


 


As part of our efforts
to streamline operations and to cut costs in the future, we may decide to outsource aspects of our manufacturing processes and
other functions. If our contract manufacturers or other outsourcers fail to perform their obligations in a timely manner or at
satisfactory quality levels, our ability to bring products to market and our reputation could suffer. For example, during a market
upturn, our contract manufacturers may be unable to meet our demand requirements, which may preclude us from fulfilling our customers’
orders on a timely basis. The ability of these manufacturers to perform is largely outside of our control. Additionally, outsourcing
may take place in developing countries and, as a result, may be subject to geopolitical uncertainty.


 


The success of our businesses will depend
on our ability to effectively develop and implement strategic business initiatives.


 


We are currently implementing
various strategic business initiatives. In connection with the development and implementation of these initiatives, we will incur
additional expenses and capital expenditures to implement the initiatives. The development and implementation of these initiatives
also requires management to divert a portion of its time from day-to-day operations. These expenses and diversions could have a
significant impact on our operations and profitability, particularly if the initiatives prove to be unsuccessful. Moreover, if
we are unable to implement an initiative in a timely manner, or if those initiatives turn out to be ineffective or are executed
improperly, our business and operating results would be adversely affected.


 




    	D-6



    	 



    

 


Failure to successfully reduce our current
or future production costs may adversely affect our financial results.


 


A significant portion of
our strategy will rely upon our ability to successfully rationalize and improve the efficiency of our operations. In particular,
our strategy relies on our ability to reduce our production costs in order to remain competitive. If we are unable to continue
to successfully implement cost reduction measures, especially in a time of a worldwide economic downturn, or if these efforts do
not generate the level of cost savings that we expect going forward or result in higher than expected costs, there could be a material
adverse effect on our business, financial condition, results of operations, or cash flows.


 


If we are unable to make necessary capital
investments or respond to pricing pressures, our business may be harmed.


 


In order to remain competitive,
we need to invest in research and development, manufacturing, customer service and support, and marketing. From time to time, we
may have to adjust the prices of our products and services to remain competitive. We may not have available sufficient financial
or other resources to continue to make investments necessary to maintain our competitive position.


 


Failure to obtain sufficient supply of component
materials to conduct our business may have an adverse effect on our production and revenue targets.


 


Our component and materials’
suppliers may fail to meet our needs. We intend to manufacture our products using materials and components procured from a limited
number of third-party suppliers. We do not currently have long-term supply contracts with our suppliers. This generally serves
to reduce our commitment risk, but does expose us to supply risk and to price increases that we may have to pass on to our customers.
In some cases, supply shortages and delays in delivery may result in curtailed production or delays in production, which can contribute
to an increase in inventory levels and loss of profit. We expect that shortages and delays in deliveries of some components will
occur from time to time. If we are unable to obtain sufficient components on a timely basis, we may experience manufacturing delays,
which could harm our relationships with current or prospective customers and reduce our sales. We may also not be able to obtain
competitive pricing for some of our supplies compared to our competitors. We also cannot assure that the component and materials
from domestic suppliers will be of similar quality or quantity as those imported component and materials, which may lead to rejections
of component and materials by our customers. In the event the domestic component and materials do not perform as well as the imported
component and materials or do not perform at all, our business, financial condition, and results of operations could be adversely
affected.


 


We have limited product distribution experience
and we expect to rely on third parties who may not successfully sell our products.


 


We have limited product
distribution experience and currently rely and plan to rely primarily on product distribution arrangements with third parties.
We may also license our technology to certain third parties for commercialization of certain applications. We expect to enter into
distribution agreements and/or licensing agreements in the future, and we may not be able to enter into these agreements on terms
that are favorable to us, if at all. In addition, we may have limited or no control over the distribution activities of these third
parties. These third parties could sell competing products and may devote insufficient sales efforts to our products. As a result,
our future revenues from sales of our products, if any, will depend on the success of the efforts of these third parties.


 


We could face significant liabilities in
connection with our technology, products, and business operations, which if incurred beyond any insurance limits, would adversely
affect our business and financial condition. 


 


We are subject to a variety
of potential liabilities connected to our technology development and business operations, such as potential liabilities related
to environmental risks. As a business which manufactures and/or markets products for use by consumers and institutions, we may
become liable for any damage caused by our products, whether used in the manner intended or not. Any such claim of liability, whether
meritorious or not, could be time-consuming and/or result in costly litigation. Although we intend to obtain insurance against
certain of these risks, no assurance can be given that such insurance will be adequate to cover related liabilities or will be
available in the future or, if available, that premiums will be commercially justifiable. If we were to incur any substantial liability
and related damages were not covered by our insurance or exceeded policy limits, or if we were to incur such liability at a time
when we are not able to obtain liability insurance, our business, financial conditions, and results of operations could be materially
adversely affected.


 




    	D-7



    	 



    

 


Our failure to protect our intellectual
property rights may undermine our competitive position, and litigation to protect our intellectual property rights or defend against
third-party allegations of infringement may be costly.


 


Our success will depend
in part on our ability to develop patentable products and obtain and enforce patent protection for our products in the United States
and other countries. We intend to file applications, as appropriate, for patents covering our products. Patents may not be issued
for any pending or future patent applications owned by or licensed to us, and the claims allowed under any issued patents may not
be sufficiently broad to protect our technology. Any issued patents owned by or licensed to us may be challenged, invalidated,
or circumvented, and the rights under these patents may not provide us with competitive advantages. In addition, competitors may
design around our technology or develop competing technologies. Intellectual property rights may also be unavailable or limited
in some foreign countries, which could make it easier for competitors to capture increased market position. We could incur substantial
costs to defend suits brought against us or suits in which we may assert our patent rights against others. An unfavorable outcome
of any such litigation could materially adversely affect our business and results of operations.


 


We may also rely on trade
secrets and proprietary know-how with which we seek to protect our products, in part by confidentiality agreements with our collaborators,
employees, and consultants. Nevertheless, these agreements afford only limited protection, and the actions we take to protect our
intellectual property rights may not be adequate. These agreements may be breached, and we may not have adequate remedies for any
breach. In addition, our trade secrets may otherwise become known or be independently developed by our competitors. As a result,
third parties may infringe or misappropriate our proprietary technologies or other intellectual property rights, which could have
a material adverse effect on our business, financial condition, or operating results.


 


In addition, policing unauthorized
use of proprietary technology can be difficult and expensive. Litigation may be necessary to enforce our intellectual property
rights, protect our trade secrets, or determine the validity and scope of the proprietary rights of others. We cannot assure you
that the outcome of any litigation will be in our favor. Intellectual property litigation may be costly and may divert management
attention, as well as expend our other resources away from our business. An adverse determination in any such litigation will impair
our intellectual property rights and may harm our business, prospects, and reputation. In addition, we have no insurance coverage
against litigation costs and would have to bear all costs arising from such litigation to the extent we are unable to recover them
from other parties. The occurrence of any of the foregoing could have a material adverse effect on our business, results of operations,
and financial condition.


 


Operational and Structural
Risks


 


We can provide no assurances as to our future
financial performance or the investment result of a purchase of our common stock.


 


Any projected results of
operations involve significant risks and uncertainty, should be considered speculative, and depend on various assumptions which
may not be correct. The future performance of our Company and the return on our common stock depends on a complex series of events
that are beyond our control and that may or may not occur. Actual results for any period may or may not approximate any assumptions
that are made and may differ significantly from such assumptions. We can provide no assurance or prediction as to our future profitability
or to the ultimate success of an investment in our common stock.


 


The compensation we pay to our executive
officers and employees will likely increase, which will affect our future profitability.


 


We believe that the compensation
we have historically paid to our executive officers is within the lower quartile of compensation paid by companies similar to our
Company. An increase in compensation and bonuses payable to our executive officers and employees could decrease our net income.


 




    	D-8



    	 



    

 


As a public reporting company, we are subject
to new corporate governance and internal control reporting requirements, and our costs related to compliance with, or our failure
to comply with existing and future requirements, could adversely affect our business.


 


We may face new corporate
governance requirements under the Sarbanes-Oxley Act of 2002, as well as new rules and regulations subsequently adopted by the
Securities and Exchange Commission (the “SEC”) and the Public Company Accounting Oversight Board. These laws, rules,
and regulations continue to evolve and may become increasingly stringent in the future. We are required to evaluate our internal
control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”). We are a smaller
reporting company as defined in Rule 12b-2 under the Exchange Act. Section 404 requires us to include an internal control report
with our Annual Report on Form 10-K. The report must include management’s assessment of the effectiveness of our internal
control over financial reporting as of the end of the fiscal year. This report must also include disclosure of any material weaknesses
in internal control over financial reporting that we have identified. Failure to comply, or any adverse results from such evaluation,
could result in a loss of investor confidence in our financial reports and have an adverse effect on the trading price of our securities.
We strive to continuously evaluate and improve our control structure to help ensure that we comply with Section 404. The financial
cost of compliance with these laws, rules, and regulations is expected to remain substantial. We cannot assure you that we will
be able to fully comply with these laws, rules, and regulations that address corporate governance, internal control reporting,
and similar matters. Failure to comply with these laws, rules, and regulations could materially adversely affect our reputation,
financial condition, and the value of our securities.


 


As a public company, we will have significant
operating costs relating to compliance requirements and our management is required to devote substantial time to compliance initiatives.


 


Our management has only
limited experience operating AbTech Industries as a public company. To operate effectively, we will be required to continue to
implement changes in certain aspects of our business and develop, manage, and train management level and other employees to comply
with on-going public company requirements. Failure to take such actions, or delay in the implementation thereof, could have a material
adverse effect on our business, financial condition, and results of operations.


 


The Sarbanes-Oxley Act,
as well as rules subsequently implemented by the SEC, impose various requirements on public companies, including requiring establishment
and maintenance of effective disclosure and financial controls and changes in corporate governance practices. Our management and
other personnel will need to devote a substantial amount of time to these new compliance initiatives. Moreover, these rules and
regulations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly.


 


Risks Related to our
Common Stock


 


A limited public trading market exists for
our common stock, which makes it more difficult for our stockholders to sell their common stock in the public markets.


 


Although our common stock
is quoted on the OTCQB under the symbol “ABHD,” there is a limited public market for our common stock. No assurance
can be given that an active market will develop or that a stockholder will ever be able to liquidate its shares of common stock
without considerable delay, if at all. Many brokerage firms may not be willing to effect transactions in the securities. Even if
a purchaser finds a broker willing to effect a transaction in these securities, the combination of brokerage commissions, state
transfer taxes, if any, and any other selling costs may exceed the selling price. Furthermore, our stock price may be impacted
by factors that are unrelated or disproportionate to our operating performance. These market fluctuations, as well as general economic,
political, and market conditions, such as recessions, interest rates, or international currency fluctuations may adversely affect
the market price and liquidity of our common stock.


 


Our stock price may be volatile.


 


The market price of our
common stock is likely to be highly volatile and could fluctuate widely in price in response to various factors, many of which
are beyond our control, including the following:


 


•            limited “public
float” in the hands of a small number of persons whose sales (or lack of sales) could result in positive or negative pricing
pressure on the market price for our common stock;


•            actual or anticipated
variations in our quarterly operating results;


•            changes in our
earnings estimates;


•            our ability to
obtain adequate working capital financing;


•            changes in market
valuations of similar companies;


•            publication (or
lack of publication) of research reports about us;


•            changes in applicable
laws or regulations, court rulings, enforcement and legal actions;


•            loss of any strategic
relationships;


•            additions or
departures of key management personnel;


•            actions by our
stockholders (including transactions in our shares);


•            speculation in
the press or investment community;


 




    	D-9



    	 



    

 


•            increases in
market interest rates, which may increase our cost of capital;


•            changes in our
industry;


•            competitive pricing
pressures;


•            our ability to
execute our business plan; and


•            economic and
other external factors.


In addition, the securities
markets have from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance
of particular companies. These market fluctuations may also materially and adversely affect the market price of our common stock.


 


Our common stock may be subject to the penny
stock rules which may make it more difficult to sell our common stock.


 


The SEC has adopted regulations
which generally define a “penny stock” to be any equity security that has a market price, as defined, less than $5.00
per share or an exercise price of less than $5.00 per share, subject to certain exceptions. Our securities may be covered by the
penny stock rules, which impose additional sales practice requirements on broker-dealers who sell to persons other than established
customers and accredited investors, such as institutions with assets in excess of $5,000,000 or an individual with net worth in
excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with his or her spouse. For transactions covered by
this rule, the broker-dealers must make a special suitability determination for the purchase and receive the purchaser’s
written agreement of the transaction prior to the sale. Consequently, the rule may affect the ability of broker-dealers to sell
our securities and also affect the ability of our stockholders to sell their shares in the secondary market.


 


FINRA sales practice requirements may also
limit a shareholder’s ability to buy and sell our stock. 


 


In addition to the “penny
stock” rules described above, the Financial Industry Regulatory Authority (“FINRA”) has adopted rules that require
that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment
is suitable for that customer. Prior to recommending speculative, low priced securities to their non-institutional customers, broker-dealers
must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives,
and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative,
low priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers
to recommend that their customers buy our common stock, which may limit your ability to buy and sell our stock and have an adverse
effect on the market for our shares.


 


Our common shares are currently traded at
low volume, and you may be unable to sell at or near ask prices or at all if you need to sell or liquidate a substantial number
of shares at one time. 


 


We cannot predict the extent
to which an active public market for our common stock will develop or be sustained. Our common shares are currently traded, but
currently with low volume, based on quotations on the “Over-the-Counter Bulletin Board,” meaning that the number of
persons interested in purchasing our common shares at or near bid prices at any given time may be relatively small or non-existent.
This situation is attributable to a number of factors, including the fact that we are a small company which is still relatively
unknown to stock analysts, stock brokers, institutional investors, and others in the investment community that generate or influence
sales volume, and that even if we came to the attention of such persons, they tend to be risk-averse and would be reluctant to
follow an unproven company such as ours or purchase or recommend the purchase of our shares until such time as we became more seasoned
and viable. As a consequence, there may be periods of several days or more when trading activity in our shares is minimal or non-existent,
as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous
sales without an adverse effect on share price. We cannot give you any assurance that a broader or more active public trading market
for our common stock will develop or be sustained, or that trading levels will be sustained.


 


Shareholders should be
aware that, according to SEC Release No. 34-29093, the market for “penny stocks” has suffered in recent years from
patterns of fraud and abuse. Such patterns include: (1) control of the market for the security by one or a few broker-dealers that
are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and
false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections
by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5)
the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level,
along with the resulting inevitable collapse of those prices and with consequent investor losses. Our management is aware of the
abuses that have occurred historically in the penny stock market, and we do not expect to be in a position to dictate the behavior
of the market or of broker-dealers who participate in the market. The occurrence of these patterns or practices could increase
the future volatility of our share price.


 




    	D-10



    	 



    

 


We have historically not paid dividends
and do not intend to pay dividends for the foreseeable future.


 


We have historically not
paid dividends to our stockholders, and management does not anticipate paying any cash dividends on our common stock to our stockholders
for the foreseeable future. Any determination we make regarding dividends will be at the discretion of our Board of Directors and
will depend on our results of operations, our financial condition, contractual restrictions, restrictions imposed by applicable
law, and other factors our Board of Directors deem relevant. Even if the funds are legally available for distribution, we may nevertheless
decide not to pay any dividends. We presently intend to retain future earnings, if any, for use in the operation and expansion
of our business.


 


The elimination of monetary liability against
our directors, officers, and employees under Nevada law and the existence of indemnification rights to our directors, officers,
and employees may result in substantial expenditures by our Company and may discourage lawsuits against our directors, officers,
and employees. 


 


Our articles of incorporation
contain a provision permitting us to eliminate the personal liability of our directors to our Company and shareholders for damages
for breach of fiduciary duty as a director or officer to the extent provided by Nevada law. We may also have contractual indemnification
obligations under our employment agreements with our officers. The foregoing indemnification obligations could result in our Company
incurring substantial expenditures to cover the cost of settlement or damage awards against directors and officers, which we may
be unable to recoup. These provisions and resultant costs may also discourage our Company from bringing a lawsuit against directors
and officers for breaches of their fiduciary duties, and may similarly discourage the filing of derivative litigation by our shareholders
against our directors and officers even though such actions, if successful, might otherwise benefit our Company and shareholders.


 


FURTHER INFORMATION


 


The statements contained in this offering package
constitute only a brief summary of certain provisions of the documents referred to herein and the transactions contemplated hereby
and thereby. The statements contained herein do not purport to be a complete description of every term and condition of such documents
and are qualified in their entirety by reference to such documents. As with any summary, some details and exceptions have been
omitted. If any of the statements herein are in conflict with any of the terms of any of such documents, the terms of such documents
will govern. Reference is made to the actual documents for a compete understanding of what they contain. Copies of all documents
in connection with the transactions described herein are available for inspection at our offices, including our Certificate of
Incorporation with the transactions described in this memorandum and Bylaws. In addition, the Company is subject to the periodic
reporting requirements of the Securities and Exchange Act of 1934, as amended and files reports with the Securities and Exchange
Commission. Such periodic reports can be accessed at www.sec.gov. Each prospective investor and his or her advisor are invited
and encouraged to ask questions of the Company with respect to the terms and conditions of the Offering and our business and request
additional information necessary to verify information contained herein. We will seek to provide answers and such information to
the extent possessed or obtainable without unreasonable effort or expense. Offerees may be required to execute non-disclosure agreements
as a prerequisite to reviewing documents determined by the Company to contain proprietary, confidential, or otherwise sensitive
information. For further information contact Lane J. Castleton, Chief Financial Officer, AbTech Holdings, Inc., 4110 N. Scottsdale
Road, Scottsdale, AZ 85251.


 




    	D-11